<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">F1000Research</journal-id>
            <journal-title-group>
                <journal-title>F1000Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2046-1402</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/f1000research.125780.3</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Research Article</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Seroprevalence of exposure to SARS-CoV-2 in domestic dogs and cats and its relationship with COVID-19 cases in the city of Villavicencio, Colombia</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 3; peer review: 2 approved]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Jaramillo Hern&#x00e1;ndez</surname>
                        <given-names>Dumar Alexander</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Funding Acquisition</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0003-1377-1747</uri>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Chac&#x00f3;n</surname>
                        <given-names>Mar&#x00ed;a Clara</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Vel&#x00e1;squez</surname>
                        <given-names>Mar&#x00ed;a Alejandra</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>V&#x00e1;squez-Trujillo</surname>
                        <given-names>Adolfo</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>S&#x00e1;nchez</surname>
                        <given-names>Ana Patricia</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <xref ref-type="aff" rid="a3">3</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Salazar Garces</surname>
                        <given-names>Luis Fabian</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Funding Acquisition</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-5128-7211</uri>
                    <xref ref-type="corresp" rid="c2">b</xref>
                    <xref ref-type="aff" rid="a4">4</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Garc&#x00ed;a</surname>
                        <given-names>Gina Lorena</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Velasco-Santamar&#x00ed;a</surname>
                        <given-names>Yohana Mar&#x00ed;a</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-6845-1663</uri>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Pedraza</surname>
                        <given-names>Luz Natalia</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Lesmes-Rodr&#x00ed;guez</surname>
                        <given-names>Lida Carolina</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Funding Acquisition</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a5">5</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>Escuela de Ciencias Animales, Universidad de los Llanos, Villavicencio, Meta, 1745, Colombia</aff>
                <aff id="a2">
                    <label>2</label>Programa de Medicina Veterinaria y Zootecnia, Escuela de Ciencias Animales, Facultad de Ciencias Agropecuarias y Recursos Naturales, Universidad de los Llanos, Villavicencio, Meta, 1745, Colombia</aff>
                <aff id="a3">
                    <label>3</label>Secretaria de Salud Municipal, Alcald&#x00ed;a de Villavicencio, Villavicencio, Meta, 110221, Colombia</aff>
                <aff id="a4">
                    <label>4</label>Research and Development Department (DIDE), Faculty of Health Sciences, Technical University of Ambato, Ambato, Ambato, Av. Colombia and Chile s/n, Ecuador</aff>
                <aff id="a5">
                    <label>5</label>Departamento de Biolog&#x00ed;a &amp; Qu&#x00ed;mica, Facultad de Ciencias B&#x00e1;sicas e Ingenier&#x00ed;a, Universidad de los Llanos, Villavicencio, Meta, 1745, Colombia</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:dumar.jaramillo@unillanos.edu.co">dumar.jaramillo@unillanos.edu.co</email>
                </corresp>
                <corresp id="c2">
                    <label>b</label>
                    <email xlink:href="mailto:lf.salazar@uta.edu.ec">lf.salazar@uta.edu.ec</email>
                </corresp>
                <fn fn-type="conflict">
                    <p>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>10</day>
                <month>8</month>
                <year>2023</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2022</year>
            </pub-date>
            <volume>11</volume>
            <elocation-id>1184</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>3</day>
                    <month>7</month>
                    <year>2023</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2023 Jaramillo Hern&#x00e1;ndez DA et al.</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://f1000research.com/articles/11-1184/pdf"/>
            <abstract>
                <p>
                    <bold>Background</bold>: Since the beginning of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak, different animal species have been implicated as possible intermediate hosts that could facilitate the transmission of the virus between species. The detection of these hosts has intensified, reporting wild, zoo, farm, and pet animals. The goal of this study was to determine the seroprevalence of anti-SARS-CoV-2 immunoglobulins (IgG) in domestic dogs and cats and its epidemiological association with the frequency of coronavirus disease 2019 (COVID-19) patients in Villavicencio, Colombia.</p>
                <p>
                    <bold>Methods:</bold> 300 dogs and 135 cats were randomly selected in a two-stage distribution by clusters according to COVID-19 cases (positive RT-qPCR for SARS-CoV-2) within the human population distributed within the eight communes of Villavicencio. Indirect enzyme-linked immunosorbent assay (ELISA) technique was applied in order to determine anti-SARS-CoV-2 IgG in sera samples. Kernel density estimation was used to compare the prevalence of COVID-19 cases with the seropositivity of dogs and cats.</p>
                <p>
                    <bold>Results:</bold> The overall seroprevalence of anti-SARS-CoV-2 IgG was 4.6% (95% CI=3.2-7.4). In canines, 3.67% (95% CI=2.1-6.4) and felines 6.67% (95% CI=3.6-12.18). Kernel density estimation indicated that seropositive cases were concentrated in the southwest region of the city. There was a positive association between SARS-CoV-2 seropositivity in pet animals and their habitat in Commune 2 (adjusted OR=5.84; 95% CI=1.1-30.88). Spearman's correlation coefficients were weakly positive (
                    <italic toggle="yes">p</italic>=0.32) between the ratio of COVID-19 cases in November 2020 and the results for domestic dogs and cats from the eight communes of Villavicencio.</p>
                <p>
                    <bold>Conclusions:</bold> In the present research cats were more susceptible to SARS-CoV-2 infection than dogs. This study provides the first positive results of anti-SARS-CoV-2 ELISA serological tests in domestic dogs and cats in Colombia with information about the virus transmission dynamics in Latin America during the COVID-19 pandemic.</p>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>anthropozoonosis</kwd>
                <kwd>coronavirus</kwd>
                <kwd>immunoassay</kwd>
                <kwd>public health</kwd>
            </kwd-group>
            <funding-group>
                <award-group id="fund-1">
                    <funding-source>Secretary of Health of the city of Villavicencio</funding-source>
                </award-group>
                <award-group id="fund-2">
                    <funding-source>Pharmacology Laboratory of the School of Animal Sciences of Universidad de los Llanos</funding-source>
                </award-group>
                <funding-statement>This work was supported by a grant from the Secretary of Health of the city of Villavicencio, in addition to own funds from the Pharmacology Laboratory of the School of Animal Sciences of Universidad de los Llanos.</funding-statement>
                <funding-statement>
                    <italic>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</italic>
                </funding-statement>
            </funding-group>
        </article-meta>
        <notes>
            <sec sec-type="version-changes">
                <label>Revised</label>
                <title>Amendments from Version 2</title>
                <p>The changes for this new version (third) of the manuscript are basic, following the recommendations of the referee regarding better explaining certain aspects of the justification of the study, methodology and improvement in the presentation of results (improvement of figure 3 and adding the new table 4).</p>
            </sec>
        </notes>
    </front>
    <body>
        <sec id="sec1" sec-type="intro">
            <title>Introduction</title>
            <p>Coronavirus disease 2019 (COVID-19) emerged in the Huanan Seafood Wholesale Market in Wuhan, China, in December 2019.
                <sup>
                    <xref ref-type="bibr" rid="ref1">1</xref>
                </sup> Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the causal agent of this disease, which was declared as pandemic by the World Health Organisation (WHO) on 11
                <sup>th</sup> March 2020.
                <sup>
                    <xref ref-type="bibr" rid="ref2">2</xref>
                </sup> The zoonotic origin of COVID-19 has been evidenced thanks to the high genomic similarity of SARS-CoV-2 with coronaviruses (CoV) recovered from bats
                <sup>
                    <xref ref-type="bibr" rid="ref3">3</xref>
                </sup> and pangolins, the latter considered potential intermediate hosts of the virus.
                <sup>
                    <xref ref-type="bibr" rid="ref4">4</xref>
                </sup> Betacoronaviruses such as SARS-CoV-2 belong to the family Coronaviridae. They exhibit linear single-stranded RNA of positive polarity
                <sup>
                    <xref ref-type="bibr" rid="ref5">5</xref>
                </sup> and cause respiratory and gastrointestinal diseases in mammals.
                <sup>
                    <xref ref-type="bibr" rid="ref6">6</xref>
                </sup> Even though humans are the most frequent route of transmission, it has been reported that cats (
                <italic toggle="yes">Felis catus</italic>) and dogs (
                <italic toggle="yes">Canis lupus familiaris</italic>) are susceptible to SARS-CoV-2 infection.
                <sup>
                    <xref ref-type="bibr" rid="ref7">7</xref>
                </sup> This way, reverse zoonosis (anthropozoonosis) is viable through close contact with owners during acute infections.
                <sup>
                    <xref ref-type="bibr" rid="ref8">8</xref>
                </sup>
            </p>
            <p>Since the beginning of the SARS-CoV-2 outbreak, different animal species have been implicated as possible intermediate hosts that could facilitate the virus transmission between species.
                <sup>
                    <xref ref-type="bibr" rid="ref9">9</xref>
                </sup> This is the reason why the determination of these hosts has intensified, evidencing a number of reports involving wild, zoo, farm and pet animals.
                <sup>
                    <xref ref-type="bibr" rid="ref10">10</xref>
                </sup> The zoonotic nature from which the transmission hypothesis has started, determines the importance of investigating animal species considered natural reservoirs of SARS-CoV-2.
                <sup>
                    <xref ref-type="bibr" rid="ref11">11</xref>
                </sup> However, concern for the control and reduction of the spread of the virus has led to more vigorous investigation of the role that pet animals, such as dogs and cats, play in the spread of the disease. Although a cat-to-human transmission case was reported,
                <sup>
                    <xref ref-type="bibr" rid="ref12">12</xref>
                </sup> it has been clearly defined that domestic canines and felines do not play a relevant role in the virus transmission to humans.
                <sup>
                    <xref ref-type="bibr" rid="ref8">8</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref13">13</xref>
                </sup>
            </p>
            <p>On the other hand, human-animal transmission has been widely reported.
                <sup>
                    <xref ref-type="bibr" rid="ref14">14</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref15">15</xref>
                </sup> This fact generates the need to investigate the implications for public and animal health, taking into account that animals are an epidemiological part of this pandemic.
                <sup>
                    <xref ref-type="bibr" rid="ref16">16</xref>
                </sup> Various epidemiological and experimental studies, through serological detection of antibodies against SARS-CoV-2, neutralising antibodies, and detection of viral genome by reverse transcriptase polymerase chain reaction (RT-qPCR), have confirmed SARS-CoV-2 in pet animals around the world.
                <sup>
                    <xref ref-type="bibr" rid="ref17">17</xref>
                </sup> Likewise, the occurrence of emerging variants has been described, as well as their influence on animals,
                <sup>
                    <xref ref-type="bibr" rid="ref18">18</xref>
                </sup> for example, the Alpha variant (B.1.1.7) in dogs and cats with clinical signs of myocarditis,
                <sup>
                    <xref ref-type="bibr" rid="ref19">19</xref>
                </sup> and the Delta variant (B.1.617.2) in dogs with clinical digestive and respiratory symptoms.
                <sup>
                    <xref ref-type="bibr" rid="ref20">20</xref>
                </sup> Regarding the Omicron variant (B.1.1.529), concluded that the SARS-CoV-2 virus accumulated mutations within host cells in mice, giving rise to the Omicron variant that was transmitted to humans, indicating a &#x2018;
                <italic toggle="yes">ping-pong&#x2019;</italic> (spillover and spillback) evolutionary trajectory between species.
                <sup>
                    <xref ref-type="bibr" rid="ref21">21</xref>
                </sup> Transmission of SARS-CoV-2 Delta variant (AY.127) from hamsters to humans
                <sup>
                    <xref ref-type="bibr" rid="ref22">22</xref>
                </sup> and animal-to-human transmission of SARS-CoV-2 within mink farms
                <sup>
                    <xref ref-type="bibr" rid="ref23">23</xref>
                </sup> have also been reported.</p>
            <p>Susceptibility to SARS-CoV-2 is determined by the affinity between the receptor-binding domain (RBD) of the viral spike (S) glycoprotein and the angiotensin-converting enzyme 2 (ACE2) of the host cell. Therefore, since vertebrates have conserved domains of ACE2, transmission of the virus between species becomes possible.
                <sup>
                    <xref ref-type="bibr" rid="ref24">24</xref>
                </sup> Canines have lower susceptibility to SARS-CoV-2 infection in contrast to felines
                <sup>
                    <xref ref-type="bibr" rid="ref8">8</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref25">25</xref>
                </sup> that exhibit greater respiratory pathology and efficient transmission of the virus to other felines through aerosols.
                <sup>
                    <xref ref-type="bibr" rid="ref26">26</xref>
                </sup>
            </p>
            <p>In the context of the rapid evolutionary trajectory between species that SARS-CoV-2 has been developing, and taking into account the Report No. 13 of the World Organisation for Animal Health (OIE) of 31
                <sup>st</sup> May 2022, which reported 676 outbreaks in animals affecting 23 different species in 35 countries,
                <sup>
                    <xref ref-type="bibr" rid="ref27">27</xref>
                </sup> the need for seroepidemiological monitoring in pet, wild and synanthropic animals becomes essential in order to broadly understand the adaptation, evolution and transmission of SARS-CoV-2.
                <sup>
                    <xref ref-type="bibr" rid="ref7">7</xref>
                </sup>
            </p>
            <p>In Colombia, in December 2021, a lion exhibited symptoms of infection days after being in contact with a COVID-19 positive keeper.
                <sup>
                    <xref ref-type="bibr" rid="ref28">28</xref>
                </sup> However, seroepidemiological studies of exposure to SARS-CoV-2 by pet animals have not been reported to date in the country. Since the dissemination of SARS-CoV-2 in dogs and cats is weak and short-lived, anti-SARS-COV-2 antibody detection studies are the best choice to determine the circulation of this virus in these companion animals. Of course, the indirect ELISA screening tests that detect immunoglobulin anti-RBD S1 SARS-CoV-2 are called for their greater accuracy in diagnosis.
                <sup>
                    <xref ref-type="bibr" rid="ref57">29</xref>
                </sup> The goal of the present study was to determine the seroprevalence of anti-SARS-CoV-2 immunoglobulins (Ig) class G (IgG) in domestic dogs and cats and its epidemiological association with the frequency of COVID-19 patients in Villavicencio city, Colombia.</p>
        </sec>
        <sec id="sec2" sec-type="methods">
            <title>Methods</title>
            <sec id="sec3">
                <title>Ethical considerations</title>
                <p>This research was endorsed by the Bioethics Committee of the Universidad de los Llanos, according to Minute 02 by consensus of April 6, 2021. In addition, all the owners of the dogs and cats involved in this study signed the respective informed consent.</p>
            </sec>
            <sec id="sec4">
                <title>Type of study and sample size</title>
                <p>This is a cross-sectional epidemiological study conducted in Villavicencio, Colombia. It consisted of applying a characterisation survey and taking blood samples from domestic canines and felines. The sample was estimated using the formula for size by proportions in finite populations, using the results obtained by Patterson 
                    <italic toggle="yes">et al</italic>.
                    <sup>
                        <xref ref-type="bibr" rid="ref29">30</xref>
                    </sup> as a reference of p, with SARS-CoV-2 seroprevalences of 3.3% in dogs and 5.8% in cats from Italy. The population assessed in the present study corresponded to 68,651 domestic canines and felines in Villavicencio (47,573 canines and 21,078 felines), according to estimates from the report on anti-rabies vaccination of dogs and cats in Colombia.
                    <sup>
                        <xref ref-type="bibr" rid="ref30">31</xref>
                    </sup> The confidence interval (CI) considered was 95% and the &#x2018;
                    <italic toggle="yes">Z</italic>&#x2019; value was 1.96 (1-&#x03b1;). The absolute precision considered was 0.15% (d = 0.0051).</p>
            </sec>
            <sec id="sec5">
                <title>Sampling and inclusion criteria</title>
                <p>The participants were selected based on their mandatory participation in the 2021 rabies vaccination campaign, carried out in Villavicencio (capital of Meta department) by the health secretary. A probabilistic sampling was conducted by randomly selected two-stage clusters of domestic dogs and cats from the eight communes (subdivisions) that compose the urban area of Villavicencio (
                    <xref ref-type="fig" rid="f1">Figure 1</xref>), which consisted of the random and proportional selection of individual dogs and cats, the sampling proportion of each cluster was determined according to the frequency of COVID-19 cases (RT-qPCR testing) in each commune
                    <sup>
                        <xref ref-type="bibr" rid="ref31">32</xref>
                    </sup> (according to 
                    <xref ref-type="table" rid="T1">Table 1</xref>); for this, the EpiInfo v. 3.0 software, from the US Centers for Disease Control and Prevention (CDC) was used (
                    <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/epiinfo/esp/es_index.html">https://www.cdc.gov/epiinfo/esp/es_index.html</ext-link>). The inclusion criteria considered domestic dogs and cats that had lived constantly in their homes for a minimum of two months before starting the present study. We determined as exclusion criteria, the animals that had consumed immunomodulatory medication (e.g., corticosteroid-type immunosuppressants) one week before the sampling were not included in the study.</p>
                <fig fig-type="figure" id="f1" orientation="portrait" position="float">
                    <label>Figure 1. </label>
                    <caption>
                        <title>Study zone &#x2013; eight communes of Villavicencio city, Meta state, Colombia.</title>
                        <p>This figure is an original figure produced by the authors for this article.</p>
                    </caption>
                    <graphic id="gr1" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/152500/4c11d39b-0b19-4107-9224-e9c35dc715a0_figure1.gif"/>
                </fig>
                <table-wrap id="T1" orientation="portrait" position="float">
                    <label>Table 1. </label>
                    <caption>
                        <title>Pet animal distribution among the eight communes of Villavicencio city according to coronavirus disease 2019 (COVID-19) active cases.</title>
                        <p>Active human cases (RT-qPCR) in November 2020; data from the Villavicencio Municipal Health Secretary (2021).</p>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">Commune</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">COVID-19* active cases (%)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Dogs</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Cats</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Total pet animals</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">1</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">7.4</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">22</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">10</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">32</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">2</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">10</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">30</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">14</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">44</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">3</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">3.5</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">10</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">5</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">15</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">14.3</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">43</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">19</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">62</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">5</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">22.4</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">68</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">30</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">98</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">6</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">4.8</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">14</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">7</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">21</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">7</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">18.9</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">58</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">25</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">83</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">8</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">18.7</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">55</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">25</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">80</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">
                                    <bold>Total</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">100</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">300</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">135</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">435</td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
                <p>A total of 435 blood samples were taken (300 domestic canines and 135 domestic felines). For this purpose, the authors of this study collected the blood from the jugular or cephalic vein, previous disinfection of the area with alcohol using a 21-gauge needle or vacutainer. Haemostasis was facilitated by applying pressure with sterile gauze in the sampling site for approximately 30 sec. The samples were centrifuged at 2000 g (Centrifuga Eppendorf 5424R) within three hours after being taken, and the sera were stored at -20 &#x00b0;C until analysis in a freezer (ABBA CVANF502B1). 
                    <xref ref-type="table" rid="T1">Table 1</xref> shows the representative distribution of &#x2018;n&#x2019; by commune (235 neighbourhoods) in Villavicencio.</p>
                <p>Pet animals characterization was performed through a survey applied to the owners, following the model of a SARS-CoV-2 study that involved dogs and cats with COVID-19 patients in a metropolitan area.
                    <sup>
                        <xref ref-type="bibr" rid="ref32">33</xref>
                    </sup> The characteristics of each pet recorded were: name; sex; age; species; breed; and owners&#x2019; names. This survey also inquired whether the individuals that cohabited with the pet animals (spontaneous communication) had histories of positive or negative RT-qPCR testing for COVID-19, and one of the survey questions was focused on the possibility for the owner to recognize if whether there were histories of clinical signs of the animals, such as signs in the upper or lower respiratory tract, or non-specific digestive signs (e.g., vomiting, diarrhoea, among others). Coordinates of the houses where the pets lived, were also recorded. The survey can be found as 
                    <italic toggle="yes">Extended data</italic>.
                    <sup>
                        <xref ref-type="bibr" rid="ref49">57</xref>
                    </sup>
                </p>
            </sec>
            <sec id="sec6">
                <title>Immunoassay</title>
                <p>IgG antibodies against the nucleocapsid protein (N) of SARS-CoV-2 in the sera of domestic dogs and cats were qualitatively determined using the indirect enzyme-linked immunosorbent assay (ELISA) (ID Screen
                    <sup>&#x00ae;</sup> SARS-CoV-2, double antigen multi-species [IDvet, Grabels, France]) according to the manufacturer's instructions. For cats, the kit presents 63% of sensitivity and 96% of specificity. For dogs, the kit has 36% of sensitivity and 85% of specificity. Previous papers used the ID Screen
                    <sup>&#x00ae;</sup> kit in their studies.
                    <sup>
                        <xref ref-type="bibr" rid="ref50">34</xref>
                    </sup>
                    <sup>&#x2013;</sup>
                    <sup>
                        <xref ref-type="bibr" rid="ref53">37</xref>
                    </sup> Each plate contained 96 microwells sensitised with recombinant antigen of purified N protein of SARS-CoV-2, to which the following items were added: two negative controls (NC); two positive controls (PC); and 92 problem sera previously homogenised by vortexing. The optical density (OD) reading was performed using the Cytation 3 multimodal microplate reader (BioTek Instruments, Inc. Winooski, VT, USA) with a wavelength of 450 nm. In total, 435 problem sera samples and 25 pre-pandemic canine sera previously stored at -20 &#x00b0;C were analysed. Using the OD data of each well, the sample/positive control (S/P) ratio was calculated, which was expressed as a percentage using the following formula:
                    <disp-formula id="e1">
                        <mml:math display="block">
                            <mml:mi mathvariant="normal">S</mml:mi>
                            <mml:mo>/</mml:mo>
                            <mml:mi mathvariant="normal">P</mml:mi>
                            <mml:mo>%</mml:mo>
                            <mml:mo>=</mml:mo>
                            <mml:mfrac>
                                <mml:mrow>
                                    <mml:mi>OD</mml:mi>
                                    <mml:mspace width="0.25em"/>
                                    <mml:mtext>sample</mml:mtext>
                                    <mml:mo>&#x2212;</mml:mo>
                                    <mml:mi>DO</mml:mi>
                                    <mml:mspace width="0.25em"/>
                                    <mml:mi>NC</mml:mi>
                                </mml:mrow>
                                <mml:mrow>
                                    <mml:mi>OD</mml:mi>
                                    <mml:mspace width="0.25em"/>
                                    <mml:mi>PC</mml:mi>
                                    <mml:mo>&#x2212;</mml:mo>
                                    <mml:mi>OD</mml:mi>
                                    <mml:mspace width="0.25em"/>
                                    <mml:mi>NC</mml:mi>
                                </mml:mrow>
                            </mml:mfrac>
                            <mml:mo>&#x00d7;</mml:mo>
                            <mml:mn>100</mml:mn>
                        </mml:math>
                    </disp-formula>
                </p>
                <p>The test was validated when the mean OD value of the PC was greater than 0.350, and the ratio of the mean OD values of the PC and NC was greater than three. The samples were considered positive if the S/P ratio was greater than or equal to 60%, doubtful samples or samples in the gray zone had S/P ratios between 50% and 60%, and samples with S/P ratio less than or equal to 50% were considered negative.</p>
                <p>The step-by-step protocol of this trial has been deposited under the title: Immunoassay of SARS-CoV-2 in dogs and cats V.1, DOI: 
                    <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.17504/protocols.io.5qpvorn29v4o/v1">dx.doi.org/10.17504/protocols.io.5qpvorn29v4o/v1</ext-link> in protocolos.io (
                    <ext-link ext-link-type="uri" xlink:href="https://www.protocols.io/view/immunoassay-of-sars-cov-2-in-dogs-and-cats-v-1-5qpvorn29v4o/v1">https://www.protocols.io/view/immunoassay-of-sars-cov-2-in-dogs-and-cats-v-1-5qpvorn29v4o/v1</ext-link>).</p>
            </sec>
            <sec id="sec7">
                <title>Statistical analysis</title>
                <p>The frequencies of the data obtained in the survey and transformation of quantitative variables into categories for their subsequent analysis were estimated. The punctual seroprevalence (P) of SARS-CoV-2 in pet animals in Villavicencio was expressed as a proportion using the following formula, considering 95% CI:
                    <disp-formula id="e2">
                        <mml:math display="block">
                            <mml:mi mathvariant="normal">P</mml:mi>
                            <mml:mo>%</mml:mo>
                            <mml:mo>=</mml:mo>
                            <mml:mfrac>
                                <mml:mrow>
                                    <mml:mo>#</mml:mo>
                                    <mml:mtext>of SARS</mml:mtext>
                                    <mml:mspace width="0.25em"/>
                                    <mml:mi>CoV</mml:mi>
                                    <mml:mspace width="0.25em"/>
                                    <mml:mn>2</mml:mn>
                                    <mml:mspace width="0.25em"/>
                                    <mml:mtext>seropositive cases</mml:mtext>
                                </mml:mrow>
                                <mml:mrow>
                                    <mml:mi>sample</mml:mi>
                                    <mml:mo>&#x00a0;</mml:mo>
                                    <mml:mi>size</mml:mi>
                                </mml:mrow>
                            </mml:mfrac>
                            <mml:mo>&#x00d7;</mml:mo>
                            <mml:mn>100</mml:mn>
                        </mml:math>
                    </disp-formula>
                </p>
                <p>The risk association measure odds ratio (OR), calculated by the binomial logistic regression model with 95% CI; was used in order to determine whether the frequency of active COVID-19 cases in humans by commune was related to SARS-CoV-2 seropositivity (exposure) of pet animals. Likewise, Spearman correlation was used to establish a possible relationship in the increase of cases in domestic animals at homes with COVID-19. Finally, using Kernel density analysis, the prevalence of COVID-19 in humans by commune was compared to anti-SARS-CoV-2 IgG seropositivity in domestic dogs and cats. A confidence level of 95% was used for all statistical calculations. Statistical estimates were made using the 
                    <ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/">R</ext-link> 4.2 software with the packages dplyr, MASS, corrplot and epiDispaly, and the maps using the 
                    <ext-link ext-link-type="uri" xlink:href="https://www.qgis.org/en/site/">QGIS</ext-link> 3.10 software.</p>
            </sec>
        </sec>
        <sec id="sec8" sec-type="results">
            <title>Results</title>
            <p>The overall seroprevalence of anti-SARS-CoV-2 IgG was 4.60% (95% CI = 3.2-7.4).
                <sup>
                    <xref ref-type="bibr" rid="ref49">57</xref>
                </sup> Specifically, in canines the results indicated 3.67% (95% CI = 2.1-6.4), and in felines 6.67% (95% CI = 3.6-12.18) (
                <xref ref-type="table" rid="T2">Table 2</xref>). Twenty seropositive individuals (11 canines and 9 domestic felines) were detected through the enzyme immunoassay. In general, 22 animals with a history of respiratory signs (e.g., cough, runny nose, among others) were detected, of which 9.10% (95% CI = 2.53-27.81) were seropositive for SARS-CoV-2 (
                <xref ref-type="table" rid="T3">Table 3</xref>). Additionally, seven immunoassay results were classified as doubtful (gray area). Likewise, all 25 canine pre-pandemic sera were negative (
                <xref ref-type="fig" rid="f2">Figure 2</xref>).</p>
            <table-wrap id="T2" orientation="portrait" position="float">
                <label>Table 2. </label>
                <caption>
                    <title>Characterisation of domestic canines and felines according to their SARS-CoV-2 seropositivity.</title>
                    <p>The following variables were taken into account: species, age, city communes and owners with positive or negative RT-qPCR testing.</p>
                </caption>
                <table content-type="article-table" frame="hsides">
                    <thead>
                        <tr>
                            <th align="left" colspan="2" rowspan="1" valign="top"/>
                            <th align="left" colspan="1" rowspan="1" valign="top">n</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">%</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">SARS-CoV-2 seropositivity</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">Crude OR</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">95% CI</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">Adjusted OR</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">95% CI</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td align="left" colspan="1" rowspan="2" valign="middle">
                                <bold>Species</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Canines</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">300</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">69</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">3.67% (11/300)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Felines</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">135</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">31</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">6.67% (9/135)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.87</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.76-4.64</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">2.07</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.78-5.46</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="3" valign="middle">
                                <bold>Age (Years)</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0-5</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">344</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">79</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">4.66% (16/344)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">6-10</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">78</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">18</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">3.85% (3/78)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.85</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.24-2.98</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.92</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.25-3.46</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">11-15</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">13</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">3</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">7.69% (1/13)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.85</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.22-15.2</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.61</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.16-15.93</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="8" valign="middle">
                                <bold>Communes</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">32</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">7</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0% (0/32)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">2</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">44</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">10</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">13.63% (6/44)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">4.17
                                <xref ref-type="table-fn" rid="tfn1">*</xref>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.52-11.49</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">5.84
                                <xref ref-type="table-fn" rid="tfn1">*</xref>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.1-30.88</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">3</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">15</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">3</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">6.67% (1/15)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.48</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.18-11.86</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.97</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.15-25.69</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">4</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">62</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">14</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">8.06% (5/62)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">2.13</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.75-6.12</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">3.13</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.57-17.36</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">5</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">98</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">23</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.02% (1/98)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.17</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.02-1.29</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.37</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.03-4.2</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">6</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">21</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">5</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">4.76% (1/21)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.02</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.13-8.01</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.96</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.17-23.06</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">7</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">83</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">19</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">4.82% (4/83)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.07</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.35-3.3</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">2.02</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.36-11.45</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">8</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">80</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">18</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">2.5% (2/80)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.85</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.18-4.67</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">1.04</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.21-12.21</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="2" valign="middle">
                                <bold>Owners COVID 19</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">COVID Test +</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">25</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">6</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">4% (1/25)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.13</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.01-2.56</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.09</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0-2.49</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">COVID Test -</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">410</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">94</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">4.63% (19/410)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.14</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.01-1.43</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.12</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0.01-1.56</td>
                        </tr>
                    </tbody>
                </table>
                <table-wrap-foot>
                    <p>
                        <italic toggle="yes">Note.</italic> 95% CI = confidence interval; COVID-19 = coronavirus disease 2019; OR = odds ratio; RT-qPCR = reverse transcriptase polymerase chain reaction; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.</p>
                    <fn-group content-type="footnotes">
                        <fn id="tfn1">
                            <label>*</label>
                            <p>
                                <italic toggle="yes">p</italic> &lt;0.05.</p>
                        </fn>
                    </fn-group>
                </table-wrap-foot>
            </table-wrap>
            <table-wrap id="T3" orientation="portrait" position="float">
                <label>Table 3. </label>
                <caption>
                    <title>Animals with a history of respiratory and digestive signs related to SARS-CoV-2 seropositivity.</title>
                </caption>
                <table content-type="article-table" frame="hsides">
                    <thead>
                        <tr>
                            <th align="left" colspan="1" rowspan="1" valign="top"/>
                            <th align="left" colspan="1" rowspan="1" valign="top"/>
                            <th align="left" colspan="1" rowspan="1" valign="top">No.</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">%</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">SARS-CoV-2 seropositivity</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">95% CI</th>
                            <th align="left" colspan="1" rowspan="1" valign="top">
                                <italic toggle="yes">X</italic>
                                <sup>2</sup>
                            </th>
                            <th align="left" colspan="1" rowspan="1" valign="top">
                                <italic toggle="yes">p</italic>-value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td align="left" colspan="1" rowspan="2" valign="middle">
                                <bold>Animals with respiratory signs history</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Exhibited signs</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">22</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">5.1</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">9.10% (2/22)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">2.53-27.81</td>
                            <td align="left" colspan="1" rowspan="2" valign="middle">0.8206</td>
                            <td align="left" colspan="1" rowspan="2" valign="middle">0.365</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Dis not exhibit signs</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">413</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">94.9</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">4.56% (18/395)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">2.90-7.09</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="2" valign="middle">
                                <bold>Animals with digestive signs history</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Exhibited signs</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">9</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">2.1</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0% (0/9)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">0-29.91</td>
                            <td align="left" colspan="1" rowspan="2" valign="middle">NA</td>
                            <td align="left" colspan="1" rowspan="2" valign="middle">NA</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="middle">Dis not exhibit signs</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">426</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">97.9</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">4.93% (20/406)</td>
                            <td align="left" colspan="1" rowspan="1" valign="middle">3.21-7.49</td>
                        </tr>
                    </tbody>
                </table>
                <table-wrap-foot>
                    <p>
                        <italic toggle="yes">Note.</italic> 95% CI = confidence interval; NA = no results are presented because there were no pets detected with digestive signs; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.</p>
                </table-wrap-foot>
            </table-wrap>
            <fig fig-type="figure" id="f2" orientation="portrait" position="float">
                <label>Figure 2. </label>
                <caption>
                    <title>Domestic dogs and cats with SARS-CoV-2 seropositivity from the eight communes of Villavicencio.</title>
                    <p>Ig = immunoglobulin class G; OD = optical density; SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2.</p>
                </caption>
                <graphic id="gr2" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/152500/4c11d39b-0b19-4107-9224-e9c35dc715a0_figure2.gif"/>
            </fig>
            <p>Regarding the eight communes, there was a general seroprevalence of 0, 13.63%, 6.67%, 8.06%, 1.02%, 4.76%, 4.82% and 2.5%, respectively (
                <xref ref-type="table" rid="T2">Table 2</xref>). In the map obtained through Kernel density analysis (
                <xref ref-type="fig" rid="f3">Figure 3</xref>), it is observed that the density of cases was concentrated mainly in the west of the city. Communes with higher densities of SARS-CoV-2 seropositive animals were 2 and 4 in comparison to COVID-19 cases in humans, with a greater number of positive cases in communes 5, 7 and 8. Other visible sites of concentrations of seropositive animals, though with lower density, corresponded to communes 7 and 8. Finally, communes 1, 3, 5 and 6 had densities ranging from low to zero.</p>
            <fig fig-type="figure" id="f3" orientation="portrait" position="float">
                <label>Figure 3. </label>
                <caption>
                    <title>Kernel density and prevalence distribution in humans, dogs and cats in Villavicencio.</title>
                    <p>(a) Kernel density estimate of anti-SARS-CoV-2 IgG prevalence in dogs and cats in Villavicencio. The darkest colored shade represents the highest density of seropositive animals, and the lightest colors represent sites with the lowest densities. (b) Distribution of prevalences in humans, canines, felines and in general of these two domestic species according to each commune. Commune = Commune; COVID-19 = coronavirus disease 2019; IgG = immunoglobulin class G.</p>
                </caption>
                <graphic id="gr3" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/152500/4c11d39b-0b19-4107-9224-e9c35dc715a0_figure3.gif"/>
            </fig>
            <p>Regarding the SARS-CoV-2 exposure and the risk factors analysed, a statistically significant association between SARS-CoV-2 seropositivity and Commune 2 was found (adjusted OR = 5.84; CI 95% = 1.1-30.88). On the other hand, no significant statistical association was found (
                <italic toggle="yes">p</italic> &gt;0.05) between anti-SARS-CoV-2 IgG seropositivity and the other items assessed (
                <xref ref-type="table" rid="T2">Table 2</xref>). Additionally, among the twenty seropositive animals, only one owner spontaneously confirmed to have positive RT-qPCR result for COVID-19.</p>
            <p>Additionally, a Spearman correlation of 
                <italic toggle="yes">p</italic> = 0.32 was found between the ratio of COVID-19 positive cases (RT-qPCR testing) of humans in November 2020 and domestic dogs and cats from the eight Villavicencio communes, result classified as a positive weak correlation. Finally, a strong positive correlation of 0.81 was found between the feline species and their SARS-CoV-2 seropositivity, as well as a positive correlation of 0.68 between the canine species and their SARS-CoV-2 seropositivity (
                <xref ref-type="table" rid="T4">Table 4</xref>).
                <table-wrap id="T4" orientation="portrait" position="float">
                    <label>Table 4. </label>
                    <caption>
                        <title>Spearman correlation between COVID-19 positive cases (RT-qPCR testing) of humans and domestic dogs and cats from the eight Villavicencio communes.</title>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top"/>
                                <th align="left" colspan="1" rowspan="1" valign="top">Humanos</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Caninos</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Felinos</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Mascotas</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">
                                    <bold>Caninos</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.01</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">1</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">--</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">--</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">
                                    <bold>Felinos</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.33</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.17</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">1</td>
                                <td colspan="1" rowspan="1"/>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">
                                    <bold>Mascotas</bold>
                                </td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.32</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.68</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.81
                                    <xref ref-type="table-fn" rid="tfn2">*</xref>
                                </td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">1</td>
                            </tr>
                        </tbody>
                    </table>
                    <table-wrap-foot>
                        <fn-group content-type="footnotes">
                            <fn id="tfn2">
                                <label>*</label>
                                <p>
                                    <italic toggle="yes">p-</italic>value = 0.01467.</p>
                            </fn>
                        </fn-group>
                    </table-wrap-foot>
                </table-wrap>
            </p>
        </sec>
        <sec id="sec9" sec-type="discussion">
            <title>Discussion</title>
            <p>In the present study, the seroprevalence of SARS-CoV-2 in canines was 3.67% (11/300) and in felines 6.67% (9/135). Felines had more risk of becoming infected with SARS-CoV-2 that dog (adjusted OR = 2.07; 95% CI = 0.78-5.46) (
                <xref ref-type="table" rid="T2">Table 2</xref>) this tendency was no statistically different. In similar studies, Barroso 
                <italic toggle="yes">et al</italic>.
                <sup>
                    <xref ref-type="bibr" rid="ref7">7</xref>
                </sup> found SARS-CoV-2 seroprevalence of 4.7% in dogs and 21.7% in cats in Portugal, determining that, among seropositive animals, 50% had been possibly infected by human-animal transmission. On the other hand, 33.3% of seropositive cats had possibly been infected via the cat-cat route. Colitti 
                <italic toggle="yes">et al</italic>.
                <sup>
                    <xref ref-type="bibr" rid="ref33">38</xref>
                </sup> found a SARS-CoV-2 seroprevalence of 2.3% in dogs and 16.2% in cats in Italy, and Fritz 
                <italic toggle="yes">et al.</italic>
                <sup>
                    <xref ref-type="bibr" rid="ref13">13</xref>
                </sup> found a SARS-CoV-2 seroprevalence of 15.4% in dogs and 23.5% in cats from France. In all the studies mentioned, SARS-CoV-2 prevalence was higher in cats and its transmission was mostly related to exposure to humans when they were more seropositive and more susceptible to infection.
                <sup>
                    <xref ref-type="bibr" rid="ref27">27</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref33">38</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref34">39</xref>
                </sup>
            </p>
            <p>As a result of the present study, a positive relationship between seropositivity and the age of the animals was observed.The older animals between 11 and 15 years exhibited this tendency predisposition, but it was not statistically different (adjusted OR = 1.61; 95% CI = 0.16-15.93) (
                <xref ref-type="table" rid="T2">Table 2</xref>). In this sense, a significant trend was found in the fatality and mortality rates of COVID-19 with advanced age in humans,
                <sup>
                    <xref ref-type="bibr" rid="ref35">40</xref>
                </sup> given that there is a weakened immune system, underlying chronic diseases, multiple drug therapies, lack of attention and self-care, poor environmental hygiene, loneliness, and lack of adequate support from other family members in this population.
                <sup>
                    <xref ref-type="bibr" rid="ref36">41</xref>
                </sup> These reasons could be considered with equal value in the case of animals, especially pet animals.
                <sup>
                    <xref ref-type="bibr" rid="ref37">42</xref>
                </sup> On the other hand, Shi 
                <italic toggle="yes">et al</italic>.
                <sup>
                    <xref ref-type="bibr" rid="ref25">25</xref>
                </sup> reported that three-month-old canines exhibited low susceptibility to experimental infection, contrary to the results obtained in cats, since animals aged less than 100 days and up to nine months were highly susceptible to SARS-CoV-2 infection.</p>
            <p>In the present study, no significant differences were found for respiratory and digestive symptoms of the animals sampled according to their SARS-CoV-2 seropositivity (
                <italic toggle="yes">X</italic>
                <sup>2</sup> = 0.8206; 
                <italic toggle="yes">p</italic> = 0.365) (
                <xref ref-type="table" rid="T3">Table 3</xref>). These results are similar to those reported by Pagani 
                <italic toggle="yes">et al</italic>.
                <sup>
                    <xref ref-type="bibr" rid="ref38">43</xref>
                </sup> and Shi 
                <italic toggle="yes">et al</italic>.
                <sup>
                    <xref ref-type="bibr" rid="ref25">25</xref>
                </sup> i.e., cats infected with SARS-CoV-2 were asymptomatic or highly susceptible to subclinical infections. Contrarily, in Germany, Keller 
                <italic toggle="yes">et al</italic>.
                <sup>
                    <xref ref-type="bibr" rid="ref39">44</xref>
                </sup> reported animals with mainly respiratory symptoms, describing the case of a cat with unresolved pneumonia, which was associated to the owner positive test for COVID-19. SARS-CoV-2-specific nucleic acid analysis was performed, revealing the complete genome and the presence of infection in that patient.</p>
            <p>In both canines and felines, the highest seropositivity occurred in Commune 2 (13.63% [6/44]) (
                <xref ref-type="table" rid="T2">Table 2</xref>), which is located in the southwest of Villavicencio. Despite the fact that it is a commune with a low population (19,491 inhabitants),
                <sup>
                    <xref ref-type="bibr" rid="ref40">45</xref>
                </sup> it has been reported with the highest number of inhabitants per house (6 inhabitants) in comparison to the other communes,
                <sup>
                    <xref ref-type="bibr" rid="ref41">46</xref>
                </sup> suggesting that having more than one individual infected with SARS-CoV-2 in the same household increased the risk of infection in these pet animals.
                <sup>
                    <xref ref-type="bibr" rid="ref33">38</xref>
                </sup> Likewise, this commune presented a positive association between the seropositivity of the animals sampled (adjusted OR = 5.84; 95% CI = 1.1-30.88) (
                <xref ref-type="table" rid="T2">Table 2</xref>) and the seropositivity of the owners, similarly, Colitti 
                <italic toggle="yes">et al.</italic>
                <sup>
                    <xref ref-type="bibr" rid="ref33">38</xref>
                </sup> found a positive association between COVID-19 positive owners and their felines&#x2019; SARS-CoV-2 seropositivity (OR = 2.5; 95% CI = 1.3-5.2), which may be related to the duration of the pets&#x2019; exposure to the infected owners, and the close contact of the felines with their owners, suggesting the development of antibodies in domestic animals as a consequence of viral transmission from owners.
                <sup>
                    <xref ref-type="bibr" rid="ref33">38</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref34">39</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref42">47</xref>
                </sup> In the present study, the association between positive COVID-19 cases (RT-qPCR testing) in humans versus seropositivity in canines and felines from the eight communes of Villavicencio was weakly positive (Spearman's correlation of 
                <italic toggle="yes">p</italic> = 0.32, 
                <xref ref-type="table" rid="T4">Table 4</xref>). This significance may be influenced by the characterization of the survey, where due to social fear or ignorance some owners could indicate that they were not or had not been positive for the disease, while a strong positive relationship was expected, as in the case of the study conducted by Patterson 
                <italic toggle="yes">et al.</italic>
                <sup>
                    <xref ref-type="bibr" rid="ref29">30</xref>
                </sup> in Italy. On the other hand, the study conducted by Van Aart 
                <italic toggle="yes">et al</italic>.
                <sup>
                    <xref ref-type="bibr" rid="ref43">48</xref>
                </sup> showed that none of the felines had been infected with SARS-CoV-2 despite the fact that these were living with their positive COVID-19 owners. Therefore, these associations between species should be analysed considering different factors.</p>
            <p>Animals and humans are susceptible to a large number of different coronaviruses, in fact, it has been shown that all pathogenic human coronaviruses have their origin in animals, which is why studies should focus on their role in the transmission of SARS-CoV-2.
                <sup>
                    <xref ref-type="bibr" rid="ref44">49</xref>
                </sup> In the present study, a human-animal transmission was considered based on the results of Smith 
                <italic toggle="yes">et al</italic>.
                <sup>
                    <xref ref-type="bibr" rid="ref45">50</xref>
                </sup> in the United Kingdom, who ruled out that dogs and cats were reservoirs of infection for humans. However, we cannot be sure about the trasmission direction, which will only be confirmed through further studies. Ultimately, successful elimination of SARS-CoV-2 will only be possible by assessing and controlling transmission in all susceptible animal species, a one health approach that could prevent the re-emergence of the virus in the future.
                <sup>
                    <xref ref-type="bibr" rid="ref46">51</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref47">52</xref>
                </sup> Although the 20 canine pre-pandemic sera reacted negatively to the immunodiagnosis, cross-reactions with ancestral coronaviruses in canines and felines are possible, but in low probability when are compared to commercial ELISAs with neutralizing antibody tests.
                <sup>
                    <xref ref-type="bibr" rid="ref54">53</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref55">54</xref>
                </sup> The possible cross-reactivity and the need to verify if the reactive antibodies are neutralizing for SARS-CoV-2 are the main limitations of our study; likewise, it is advisable to carry out studies of &#x201c;SARS-CoV-2 virus neutralization test from the serum bank obtained, since this is the gold-standard test for the Centers for Disease Control and Prevention (CDC).
                <sup>
                    <xref ref-type="bibr" rid="ref56">55</xref>
                </sup>
            </p>
        </sec>
        <sec id="sec10" sec-type="conclusion">
            <title>Conclusion</title>
            <p>The present study provides the first positive results of anti-SARS-CoV-2 serological tests (ELISA) in domestic dogs and cats in Colombia, with information about the dynamics of virus transmission in Latin America and the world during the COVID-19 pandemic. As mentioned above, cats were more susceptible to natural SARS-CoV-2 infection than dogs, following similar dynamics described in other studies.
                <sup>
                    <xref ref-type="bibr" rid="ref7">7</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref33">38</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref48">56</xref>
                </sup> The present study does not provide evidence that domestic canines and felines are sources of infection for humans; however, further studies focused on one health should not be ruled out
                <sup>
                    <xref ref-type="bibr" rid="ref47">52</xref>
                </sup> in order to improve our knowledge about transmission, epidemiology and dynamics of SARS-CoV-2 and promote a better response to possible future pandemics.</p>
        </sec>
        <sec id="sec11">
            <title>Data availability</title>
            <sec id="sec12">
                <title>Underlying data</title>
                <p>Figshare: Seroprevalence of exposure to SARS-CoV-2 in domestic dogs and cats and its relationship with COVID-19 cases in the city of Villavicencio, Colombia. 
                    <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.21271137.v2">https://doi.org/10.6084/m9.figshare.21271137.v2</ext-link>.
                    <sup>
                        <xref ref-type="bibr" rid="ref49">57</xref>
                    </sup>
                </p>
                <p>This project contains the following underlying data:
                    <list list-type="bullet">
                        <list-item>
                            <label>-</label>
                            <p>Dataset.xlsx (data on OD IgG Anti-SARS-CoV-2, positive control sample ratio (Indirect ELISA), data on domestic dogs and cats that participated in the project.)</p>
                        </list-item>
                    </list>
                </p>
            </sec>
            <sec id="sec13">
                <title>Extended data</title>
                <p>Figshare: Seroprevalence of exposure to SARS-CoV-2 in domestic dogs and cats and its relationship with COVID-19 cases in the city of Villavicencio, Colombia. 
                    <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.21271137.v2">https://doi.org/10.6084/m9.figshare.21271137.v2</ext-link>.
                    <sup>
                        <xref ref-type="bibr" rid="ref49">57</xref>
                    </sup>
                </p>
                <p>This project contains the following extended data:
                    <list list-type="bullet">
                        <list-item>
                            <label>-</label>
                            <p>Consent form.docx</p>
                        </list-item>
                        <list-item>
                            <label>-</label>
                            <p>Questionnaire.docx</p>
                        </list-item>
                    </list>
                </p>
                <p>Data are available under the terms of the 
                    <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link> (CC-BY 4.0).</p>
            </sec>
        </sec>
    </body>
    <back>
        <ack>
            <title>Acknowledgements</title>
            <p>The authors are grateful to the support of the General Research Division of Universidad de los Llanos. Likewise, to professionals and other employees of the Villavicencio Municipal Health Secretary involved in the rabies vaccination program for domestic dogs and cats. An earlier version of this article can be found on SSRN: 
                <ext-link ext-link-type="uri" xlink:href="https://ssrn.com/abstract=4156064">https://ssrn.com/abstract=4156064</ext-link> or doi: 
                <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2139/ssrn.4156064">http://dx.doi.org/10.2139/ssrn.4156064</ext-link>.</p>
        </ack>
        <ref-list>
            <title>References</title>
            <ref id="ref1">
                <label>1</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Worobey</surname>
                            <given-names>M</given-names>
                        </name>
</person-group>:
                    <article-title>Dissecting the early COVID-19 cases in Wuhan.</article-title>
                    <source>

                        <italic toggle="yes">Science.</italic>
</source>
                    <year>2021</year>;<volume>374</volume>:<fpage>1202</fpage>&#x2013;<lpage>1204</lpage>.
                    <pub-id pub-id-type="pmid">34793199</pub-id>
                    <pub-id pub-id-type="doi">10.1126/science.abm4454</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref2">
                <label>2</label>
                <mixed-citation publication-type="other">
                    <collab>World Health Organization (WHO)</collab>:
                    <article-title>WHO Director-General&#x2019;s opening remarks at the media briefing on COVID-19-11 March 2020.</article-title>
                    <year>2020 [cited 2022 March 6]</year>.
                    <ext-link ext-link-type="uri" xlink:href="https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref3">
                <label>3</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Zhou</surname>
                            <given-names>P</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Yang</surname>
                            <given-names>XL</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Wang</surname>
                            <given-names>XG</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>A pneumonia outbreak associated with a new coronavirus of probable bat origin.</article-title>
                    <source>

                        <italic toggle="yes">Nature.</italic>
</source>
                    <year>2020</year>;<volume>579</volume>:<fpage>270</fpage>&#x2013;<lpage>273</lpage>.
                    <pub-id pub-id-type="pmid">32015507</pub-id>
                    <pub-id pub-id-type="doi">10.1038/s41586-020-2012-7</pub-id>
                    <ext-link ext-link-type="uri" xlink:href="https://www.nature.com/articles/s41586-020-2012-7">Publisher Full Text</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref4">
                <label>4</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Zhang</surname>
                            <given-names>T</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Qunfu</surname>
                            <given-names>W</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Zhang</surname>
                            <given-names>Z</given-names>
                        </name>
</person-group>:
                    <article-title>Probable Pangolin origin of SARS-CoV-2 associated with the COVID-19 Outbreak.</article-title>
                    <source>

                        <italic toggle="yes">Curr. Biol.</italic>
</source>
                    <year>2020</year>;<volume>30</volume>(<issue>7</issue>):<fpage>1346</fpage>&#x2013;<lpage>1351.e2</lpage>.
                    <pub-id pub-id-type="pmid">32197085</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.cub.2020.03.022</pub-id>
                    <ext-link ext-link-type="uri" xlink:href="https://www.cell.com/current-biology/fulltext/S0960-9822(20)30360-2?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0960982220303602%3Fshowall%3Dtrue">Publisher Full Text</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref5">
                <label>5</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Phan</surname>
                            <given-names>T</given-names>
                        </name>
</person-group>:
                    <article-title>Novel coronavirus: from discovery to clinical diagnostics.</article-title>
                    <source>

                        <italic toggle="yes">Infect. Genet. Evol.</italic>
</source>
                    <year>2020</year>;<volume>79</volume>(<issue>104211</issue>):<fpage>104211</fpage>.
                    <pub-id pub-id-type="pmid">32007627</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.meegid.2020.104211</pub-id>
                    <ext-link ext-link-type="uri" xlink:href="https://www.sciencedirect.com/science/article/pii/S1567134820300435?via%3Dihub">Publisher Full Text</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref6">
                <label>6</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Erles</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Brownlie</surname>
                            <given-names>J</given-names>
                        </name>
</person-group>:
                    <article-title>Canine respiratory coronavirus: an emerging pathogen in the canine infectious respiratory disease complex.</article-title>
                    <source>

                        <italic toggle="yes">Vet. Clin. North Am. Small Anim. Pract.</italic>
</source>
                    <year>2008</year>;<volume>38</volume>(<issue>4</issue>):<fpage>815</fpage>&#x2013;<lpage>825</lpage>.
                    <pub-id pub-id-type="pmid">18501280</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.cvsm.2008.02.008</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref7">
                <label>7</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Barroso</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Vieira-Pires</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Antunes</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Susceptibility of pets to SARS-CoV-2 infection: Lessons from a seroepidemiologic survey of cats and dogs in Portugal.</article-title>
                    <source>

                        <italic toggle="yes">Microorganisms.</italic>
</source>
                    <year>2022</year>;<volume>10</volume>(<issue>2</issue>):<fpage>345</fpage>.
                    <pub-id pub-id-type="pmid">35208799</pub-id>
                    <pub-id pub-id-type="doi">10.3390/microorganisms10020345</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref8">
                <label>8</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Bosco-Lauth</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hartwig</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Porter</surname>
                            <given-names>S</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats.</article-title>
                    <source>

                        <italic toggle="yes">Proc. Natl. Acad. Sci. U. S. A.</italic>
</source>
                    <year>2020</year>;<volume>117</volume>(<issue>42</issue>):<fpage>26382</fpage>&#x2013;<lpage>26388</lpage>.
                    <pub-id pub-id-type="pmid">32994343</pub-id>
                    <pub-id pub-id-type="doi">10.1073/pnas.2013102117</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref9">
                <label>9</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Jaimes</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Andr&#x00e9;</surname>
                            <given-names>N</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Chappie</surname>
                            <given-names>J</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Phylogenetic analysis and structural modeling of SARS-CoV-2 spike protein reveals an evolutionary distinct and proteolytically sensitive activation loop.</article-title>
                    <source>

                        <italic toggle="yes">J. Mol. Biol.</italic>
</source>
                    <year>2020</year>;<volume>432</volume>(<issue>10</issue>):<fpage>3309</fpage>&#x2013;<lpage>3325</lpage>.
                    <pub-id pub-id-type="pmid">32320687</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.jmb.2020.04.009</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref10">
                <label>10</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Goraichuk</surname>
                            <given-names>V</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Arefiev</surname>
                            <given-names>V</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Borys</surname>
                            <given-names>T</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Zoonotic and reverse zoonotic transmissibility of SARS-CoV-2.</article-title>
                    <source>

                        <italic toggle="yes">Virus Res.</italic>
</source>
                    <year>2021</year>;<volume>302</volume>(<issue>198473</issue>):<fpage>198473</fpage>.
                    <pub-id pub-id-type="pmid">34118360</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.virusres.2021.198473</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref11">
                <label>11</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Kiros</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Andualem</surname>
                            <given-names>H</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kiros</surname>
                            <given-names>T</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>COVID-19 pandemic: current knowledge about the role of pets and other animals in disease transmission.</article-title>
                    <source>

                        <italic toggle="yes">Virol. J.</italic>
</source>
                    <year>2020</year>;<volume>17</volume>(<issue>143</issue>):<fpage>143</fpage>.
                    <pub-id pub-id-type="pmid">33008410</pub-id>
                    <pub-id pub-id-type="doi">10.1186/s12985-020-01416-9</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref12">
                <label>12</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Sila</surname>
                            <given-names>T</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Sunghan</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Laochareonsuk</surname>
                            <given-names>W</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Suspected Cat-to-Human Transmission of SARS-CoV-2, Thailand, July&#x2013;September 2021.</article-title>
                    <source>

                        <italic toggle="yes">Emerg. Infect. Dis.</italic>
</source>
                    <year>2022</year>;<volume>28</volume>(<issue>7</issue>):<fpage>1485</fpage>&#x2013;<lpage>1488</lpage>.
                    <pub-id pub-id-type="pmid">35666777</pub-id>
                    <pub-id pub-id-type="doi">10.3201/eid2807.212605</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref13">
                <label>13</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Fritz</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Rosolen</surname>
                            <given-names>B</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Krafft</surname>
                            <given-names>E</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households.</article-title>
                    <source>

                        <italic toggle="yes">One Health.</italic>
</source>
                    <year>2020</year>;<volume>11</volume>(<issue>100192</issue>):<fpage>100192</fpage>.
                    <pub-id pub-id-type="pmid">33169106</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.onehlt.2020.100192</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref14">
                <label>14</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Prince</surname>
                            <given-names>T</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Smith</surname>
                            <given-names>SL</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Radford</surname>
                            <given-names>AD</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>SARS-CoV-2 infections in animals: reservoirs for reverse zoonosis and models for study.</article-title>
                    <source>

                        <italic toggle="yes">Viruses.</italic>
</source>
                    <year>2021</year>;<volume>13</volume>(<issue>3</issue>):<fpage>494</fpage>.
                    <pub-id pub-id-type="pmid">33802857</pub-id>
                    <pub-id pub-id-type="doi">10.3390/v13030494</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref15">
                <label>15</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Banerjee</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mossman</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Baker</surname>
                            <given-names>ML</given-names>
                        </name>
</person-group>:
                    <article-title>Zooanthroponotic potential of SARS-CoV-2 and implications of reintroduction into human populations.</article-title>
                    <source>

                        <italic toggle="yes">Cell Host Microbe.</italic>
</source>
                    <year>2021</year>;<volume>29</volume>:<fpage>160</fpage>&#x2013;<lpage>164</lpage>.
                    <pub-id pub-id-type="pmid">33539765</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.chom.2021.01.004</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref16">
                <label>16</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Michelitsch</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Wernike</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ulrich</surname>
                            <given-names>L</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>SARS-CoV-2 in animals: From potential hosts to animal models.</article-title>
                    <source>

                        <italic toggle="yes">Adv. Virus Res.</italic>
</source>
                    <year>2021</year>;<volume>110</volume>:<fpage>59</fpage>&#x2013;<lpage>102</lpage>.
                    <pub-id pub-id-type="pmid">34353482</pub-id>
                    <pub-id pub-id-type="doi">10.1016/bs.aivir.2021.03.004</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref17">
                <label>17</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Sit</surname>
                            <given-names>TH</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Brackman</surname>
                            <given-names>CJ</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ip</surname>
                            <given-names>SM</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Infection of dogs with SARS-CoV-2.</article-title>
                    <source>

                        <italic toggle="yes">Nature.</italic>
</source>
                    <year>2020</year>;<volume>586</volume>:<fpage>776</fpage>&#x2013;<lpage>778</lpage>.
                    <pub-id pub-id-type="pmid">32408337</pub-id>
                    <pub-id pub-id-type="doi">10.1038/s41586-020-2334-5</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref18">
                <label>18</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Chac&#x00f3;n</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Vel&#x00e1;squez</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Jaramillo-Hern&#x00e1;ndez</surname>
                            <given-names>D</given-names>
                        </name>
</person-group>:
                    <article-title>Revisi&#x00f3;n sistem&#x00e1;tica de la situaci&#x00f3;n epidemiol&#x00f3;gica y an&#x00e1;lisis gen&#x00f3;mico del SARS-CoV-2 aislado de perros y gatos dom&#x00e9;sticos.</article-title>
                    <source>

                        <italic toggle="yes">Rev. Inv. Vet. Per&#x00fa;.</italic>
</source>
                    <year>2022</year>;<volume>33</volume>(<issue>3</issue>):<fpage>e22909</fpage>.
                    <pub-id pub-id-type="doi">10.15381/rivep.v33i3.22909</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref19">
                <label>19</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Ferasin</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Fritz</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ferasin</surname>
                            <given-names>H</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Infection with SARS-CoV-2 variant B.1.1.7 detected in a group of dogs and cats with suspected myocarditis.</article-title>
                    <source>

                        <italic toggle="yes">Vet. Rec.</italic>
</source>
                    <year>2021</year>;<volume>189</volume>:<fpage>e944</fpage>.
                    <pub-id pub-id-type="pmid">34738231</pub-id>
                    <pub-id pub-id-type="doi">10.1002/vetr.944</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref20">
                <label>20</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Fern&#x00e1;ndez-Bastit</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Rodon</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pradenas</surname>
                            <given-names>E</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>First detection of SARS-CoV-2 Delta (B.1.617.2) variant of concern in a dog with clinical signs in Spain.</article-title>
                    <source>

                        <italic toggle="yes">Viruses.</italic>
</source>
                    <year>2021</year>;<volume>13</volume>:<fpage>2526</fpage>.
                    <pub-id pub-id-type="pmid">34960795</pub-id>
                    <pub-id pub-id-type="doi">10.3390/v13122526</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref21">
                <label>21</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Wei</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Shan</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Wang</surname>
                            <given-names>W</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Evidence for a mouse origin of the SARS-CoV-2 Omicron variant.</article-title>
                    <source>

                        <italic toggle="yes">J. Genet. Genomics.</italic>
</source>
                    <year>2021</year>;<volume>48</volume>(<issue>12</issue>):<fpage>1111</fpage>&#x2013;<lpage>1121</lpage>.
                    <pub-id pub-id-type="pmid">34954396</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.jgg.2021.12.003</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref22">
                <label>22</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Yen</surname>
                            <given-names>H</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Sit</surname>
                            <given-names>T</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Brackman</surname>
                            <given-names>C</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study.</article-title>
                    <source>

                        <italic toggle="yes">Lancet.</italic>
</source>
                    <year>2022</year>;<volume>399</volume>:<fpage>1070</fpage>&#x2013;<lpage>1078</lpage>.
                    <pub-id pub-id-type="pmid">35279259</pub-id>
                    <pub-id pub-id-type="doi">10.1016/S0140-6736(22)00326-9</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref23">
                <label>23</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Munnink</surname>
                            <given-names>B</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Sikkema</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Nieuwenhuijse</surname>
                            <given-names>D</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans.</article-title>
                    <source>

                        <italic toggle="yes">Science.</italic>
</source>
                    <year>2021</year>;<volume>371</volume>(<issue>6525</issue>):<fpage>172</fpage>&#x2013;<lpage>177</lpage>.
                    <pub-id pub-id-type="pmid">33172935</pub-id>
                    <pub-id pub-id-type="doi">10.1126/science.abe5901</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref24">
                <label>24</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Chen</surname>
                            <given-names>Y</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Guo</surname>
                            <given-names>Y</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pan</surname>
                            <given-names>Y</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Structure analysis of the receptor binding of 2019-nCoV.</article-title>
                    <source>

                        <italic toggle="yes">Biochem. Biophys. Res. Commun.</italic>
</source>
                    <year>2020</year>;<volume>525</volume>:<fpage>135</fpage>&#x2013;<lpage>140</lpage>.
                    <pub-id pub-id-type="pmid">32081428</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.bbrc.2020.02.071</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref25">
                <label>25</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Shi</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Wen</surname>
                            <given-names>Z</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Zhong</surname>
                            <given-names>G</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2.</article-title>
                    <source>

                        <italic toggle="yes">Science.</italic>
</source>
                    <year>2020</year>;<volume>368</volume>(<issue>368</issue>):<fpage>1016</fpage>&#x2013;<lpage>1020</lpage>.
                    <pub-id pub-id-type="pmid">32269068</pub-id>
                    <pub-id pub-id-type="doi">10.1126/science.abb7015</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref26">
                <label>26</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Gaudreault</surname>
                            <given-names>N</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Trujillo</surname>
                            <given-names>JD</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Carossino</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>SARS-CoV-2 infection, disease and transmission in domestic cats.</article-title>
                    <source>

                        <italic toggle="yes">Emerg. Microbes Infect.</italic>
</source>
                    <year>2020</year>;<volume>9</volume>:<fpage>2322</fpage>&#x2013;<lpage>2332</lpage>.
                    <pub-id pub-id-type="pmid">33028154</pub-id>
                    <pub-id pub-id-type="doi">10.1080/22221751.2020.1833687</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref27">
                <label>27</label>
                <mixed-citation publication-type="other">
                    <article-title>Organizaci&#x00f3;n Internacional de Sanidad Animal (OIE), Mapa de registro de casos de animales infectados por el SARS-CoV-2. Reporte 13.</article-title>
                    <year>2022 [cited 2022 July 3]</year>.
                    <ext-link ext-link-type="uri" xlink:href="https://www.oie.int/app/uploads/2022/02/sars-cov-2-situation-report-9.pdf">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref28">
                <label>28</label>
                <mixed-citation publication-type="other">
                    <article-title>Organizaci&#x00f3;n Internacional de Sanidad Animal (OIE), Mapa de registro de casos de animales infectados por el SARS-CoV-2. Reporte 8.</article-title>
                    <year>2022 [cited 2022 July 3]</year>.
                    <ext-link ext-link-type="uri" xlink:href="https://www.oie.int/app/uploads/2022/01/sars-cov-2-situation-report-8.pdf">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref57">
                <label>29</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Reiners</surname>
                            <given-names>N</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Schnurra</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Trawinski</surname>
                            <given-names>H</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Performance of a SARS CoV-2 antibody ELISA based on simultaneous measurement of antibodies against the viral nucleoprotein and receptor-binding domain.</article-title>
                    <source>

                        <italic toggle="yes">Eur. J. Clin. Microbiol. Infect. Dis.</italic>
</source>
                    <year>2021</year>;<volume>40</volume>:<fpage>2645</fpage>&#x2013;<lpage>2649</lpage>.
                    <pub-id pub-id-type="pmid">34085159</pub-id>
                    <pub-id pub-id-type="doi">10.1007/S10096-021-04284-5/TABLES/3</pub-id>
                    <pub-id pub-id-type="pmcid">PMC8175097</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref29">
                <label>30</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Patterson</surname>
                            <given-names>EI</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Elia</surname>
                            <given-names>G</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Grassi</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy.</article-title>
                    <source>

                        <italic toggle="yes">Nat. Commun.</italic>
</source>
                    <year>2020</year>;<volume>11</volume>(<issue>6231</issue>):<fpage>6231</fpage>.
                    <pub-id pub-id-type="pmid">33277505</pub-id>
                    <pub-id pub-id-type="doi">10.1038/s41467-020-20097-0</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref30">
                <label>31</label>
                <mixed-citation publication-type="other">
                    <collab>Ministerio de Salud y Protecci&#x00f3;n Social (MINSALUD)</collab>:
                    <article-title>Reporte de Vacunaci&#x00f3;n Antirr&#x00e1;bica de perros y gatos, Colombia a&#x00f1;o 2017.</article-title>
                    <year>2017 [cited 2022 March 7]</year>.
                    <ext-link ext-link-type="uri" xlink:href="https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/PP/SA/nacional-departamento-vacunacion-vi-2017.pdf">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref31">
                <label>32</label>
                <mixed-citation publication-type="other">
                    <collab>Secretaria de Salud Municipal de Villavicencio</collab>:
                    <article-title>La situaci&#x00f3;n de los barrios, comunas y corregiminetos de Villavicencio frente al COVID-19.</article-title>
                    <year>2021 [cited 2022 March 7]</year>.
                    <ext-link ext-link-type="uri" xlink:href="http://villavicencio.gov.co/NuestraAlcaldia/SaladePrensa/Paginas/AS%C3%8D-EST%C3%81-LA-SITUACI%C3%93N-DE-LOS-BARRIOS,-COMUNAS-Y-CORREGIMIENTOS-DE-VILLAVICENCIO-FRENTE-AL-COVID-19.aspx">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref32">
                <label>33</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Calvet</surname>
                            <given-names>GA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pereira</surname>
                            <given-names>SA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ogrzewalska</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Investigation of SARS-CoV-2 infection in dogs and cats of humans diagnosed with COVID-19 in Rio de Janeiro, Brazil.</article-title>
                    <source>

                        <italic toggle="yes">PLoS One.</italic>
</source>
                    <year>2021</year>;<volume>16</volume>(<issue>4</issue>):<fpage>e0250853</fpage>.
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0250853</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref50">
                <label>34</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Bessi&#x00e8;re</surname>
                            <given-names>P</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Vergne</surname>
                            <given-names>T</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Battini</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>SARS-CoV-2 Infection in Companion Animals: Prospective Serological Survey and Risk Factor Analysis in France.</article-title>
                    <source>

                        <italic toggle="yes">Viruses.</italic>
</source>
                    <year>2022</year>;<volume>14</volume>:<fpage>1178</fpage>.
                    <pub-id pub-id-type="pmid">35746652</pub-id>
                    <pub-id pub-id-type="doi">10.3390/v14061178</pub-id>
                    <pub-id pub-id-type="pmcid">PMC9229200</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref51">
                <label>35</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Diezma-D&#x00ed;az</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>&#x00c1;lvarez-Garc&#x00ed;a</surname>
                            <given-names>G</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Regidor-Cerrillo</surname>
                            <given-names>J</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>A comparative study of eight serological methods shows that spike protein-based ELISAs are the most accurate tests for serodiagnosing SARS-CoV-2 infections in cats and dogs.</article-title>
                    <source>

                        <italic toggle="yes">Front. Vet. Sci.</italic>
</source>
                    <year>2023</year>;<volume>10</volume>:<fpage>1121935</fpage>.
                    <pub-id pub-id-type="pmid"> 36777670</pub-id>
                    <pub-id pub-id-type="doi">10.3389/fvets.2023.1121935</pub-id>
                    <pub-id pub-id-type="pmcid"> PMC9909348</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref52">
                <label>36</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Barua</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hoque</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Adekanmbi</surname>
                            <given-names>F</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Antibodies to SARS-CoV-2 in dogs and cats, USA.</article-title>
                    <source>

                        <italic toggle="yes">Emerg. Microbes. Infect.</italic>
</source>
                    <year>2021</year>;<volume>10</volume>(<issue>1</issue>):<fpage>1669</fpage>&#x2013;<lpage>1674</lpage>.
                    <pub-id pub-id-type="pmid">34374631</pub-id>
                    <pub-id pub-id-type="doi">10.1080/22221751.2021.1967101</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref53">
                <label>37</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Neira</surname>
                            <given-names>V</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Brito</surname>
                            <given-names>B</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ag&#x00fc;ero</surname>
                            <given-names>B</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners.</article-title>
                    <source>

                        <italic toggle="yes">Emerg. Microbes. Infect.</italic>
</source>
                    <year>2021</year>;<volume>10</volume>(<issue>1</issue>):<fpage>376</fpage>&#x2013;<lpage>383</lpage>.
                    <pub-id pub-id-type="pmid">33317424</pub-id>
                    <pub-id pub-id-type="doi">10.1080/22221751.2020.1863132</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref33">
                <label>38</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Colitti</surname>
                            <given-names>B</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bertolotti</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mannelli</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Cross-Sectional serosurvey of companion animals housed with SARS-CoV-2&#x2013;infected owners, Italy.</article-title>
                    <source>

                        <italic toggle="yes">Emerg. Infect. Dis.</italic>
</source>
                    <year>2021</year>;<volume>27</volume>(<issue>7</issue>):<fpage>1919</fpage>&#x2013;<lpage>1922</lpage>.
                    <pub-id pub-id-type="pmid">33974535</pub-id>
                    <pub-id pub-id-type="doi">10.3201/eid2707.203314</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref34">
                <label>39</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Dileepan</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Di</surname>
                            <given-names>D</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Huang</surname>
                            <given-names>Q</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA.</article-title>
                    <source>

                        <italic toggle="yes">Virulence.</italic>
</source>
                    <year>2021</year>;<volume>12</volume>(<issue>1</issue>):<fpage>1597</fpage>&#x2013;<lpage>1609</lpage>.
                    <pub-id pub-id-type="pmid">34125647</pub-id>
                    <pub-id pub-id-type="doi">10.1080/21505594.2021.1936433</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref35">
                <label>40</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Esmaeili</surname>
                            <given-names>DE</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Fajari</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Naguili</surname>
                            <given-names>B</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Case fatality and mortality rates, socio-demographic profile, and clinical features of COVID-19 in the elderly population: A population-based registry study in Iran.</article-title>
                    <source>

                        <italic toggle="yes">J. Med. Virol.</italic>
</source>
                    <year>2022</year>;<volume>94</volume>:<fpage>2126</fpage>&#x2013;<lpage>2132</lpage>.
                    <pub-id pub-id-type="pmid">35032041</pub-id>
                    <pub-id pub-id-type="doi">10.1002/jmv.27594</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref36">
                <label>41</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Liu</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Chen</surname>
                            <given-names>Y</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lin</surname>
                            <given-names>R</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients.</article-title>
                    <source>

                        <italic toggle="yes">J. Infect.</italic>
</source>
                    <year>2020</year>;<volume>80</volume>:<fpage>e14</fpage>&#x2013;<lpage>e18</lpage>.
                    <pub-id pub-id-type="pmid">32171866</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.jinf.2020.03.005</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref37">
                <label>42</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Pati</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Panda</surname>
                            <given-names>SK</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Acharya</surname>
                            <given-names>AP</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Evaluation of geriatric changes in dogs.</article-title>
                    <source>

                        <italic toggle="yes">Veterinary world.</italic>
</source>
                    <year>2015</year>;<volume>8</volume>(<issue>3</issue>):<fpage>273</fpage>&#x2013;<lpage>278</lpage>.
                    <pub-id pub-id-type="pmid">27047084</pub-id>
                    <pub-id pub-id-type="doi">10.14202/vetworld.2015.273-278</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref38">
                <label>43</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Pagani</surname>
                            <given-names>G</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lai</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bergna</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Human-to-Cat SARS-CoV-2 transmission: Case report and full-genome sequencing from an infected pet and its owner in northern Italy.</article-title>
                    <source>

                        <italic toggle="yes">Pathogens.</italic>
</source>
                    <year>2021</year>;<volume>10</volume>(<issue>252</issue>).
                    <pub-id pub-id-type="pmid">33672421</pub-id>
                    <pub-id pub-id-type="doi">10.3390/pathogens10020252</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref39">
                <label>44</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Keller</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hagag</surname>
                            <given-names>TI</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Balzer</surname>
                            <given-names>J</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Detection of SARS-CoV-2 variant B.1.1.7 in a cat in Germany.</article-title>
                    <source>

                        <italic toggle="yes">Res. Vet. Sci.</italic>
</source>
                    <year>2021</year>;<volume>140</volume>:<fpage>229</fpage>&#x2013;<lpage>232</lpage>.
                    <pub-id pub-id-type="pmid">34534904</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.rvsc.2021.09.008</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref40">
                <label>45</label>
                <mixed-citation publication-type="other">
                    <collab>Departamento Administrativo Nacional de Estad&#x00ed;stica (DANE)</collab>:
                    <article-title>Censo Nacional de Poblaci&#x00f3;n y Vivienda - CNPV &#x2013; 2018.</article-title>
                    <year>2018; [cited 2022 March 15]</year>.
                    <ext-link ext-link-type="uri" xlink:href="https://www.datos.gov.co/Estad-sticas-Nacionales/Censo-Nacional-de-Poblaci-n-y-Vivienda-CNPV-2018/qzc6-q9qw">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref41">
                <label>46</label>
                <mixed-citation publication-type="other">
                    <collab>Universidad Santo T&#x00f3;mas</collab>:
                    <article-title>Los procesos de configuraci&#x00f3;n territorial en Villavicencio a partir de la migraci&#x00f3;n hist&#x00f3;rica en el municipio.</article-title>
                    <year>2018 [cited 2022 March 15]</year>.
                    <ext-link ext-link-type="uri" xlink:href="https://repository.usta.edu.co/bitstream/handle/11634/21345/2018anagarzon.pdf?sequenc">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref42">
                <label>47</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Hamer</surname>
                            <given-names>SA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pauvolid-Corr&#x00ea;a</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Zecca</surname>
                            <given-names>IB</given-names>
                        </name>
</person-group>:
                    <article-title>SARS-CoV-2 Infections and viral isolations among serially tested cats and dogs in households with infected owners in Texas, USA.</article-title>
                    <source>

                        <italic toggle="yes">Viruses.</italic>
</source>
                    <year>2021</year>;<volume>13</volume>(<issue>5</issue>):<fpage>938</fpage>.
                    <pub-id pub-id-type="pmid">34069453</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.rvsc.2021.09.008</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref43">
                <label>48</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Van Aart</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Velkers</surname>
                            <given-names>AE</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Fischer</surname>
                            <given-names>FC</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>SARS-CoV-2 infection in cats and dogs in infected mink farms.</article-title>
                    <source>

                        <italic toggle="yes">Transbound. Emerg. Dis.</italic>
</source>
                    <year>2021</year>;<volume>69</volume>:<fpage>3001</fpage>&#x2013;<lpage>3007</lpage>.
                    <pub-id pub-id-type="pmid">34080762</pub-id>
                    <pub-id pub-id-type="doi">10.1111/tbed.14173</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref44">
                <label>49</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Cui</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Li</surname>
                            <given-names>F</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Li</surname>
                            <given-names>Z</given-names>
                        </name>
</person-group>:
                    <article-title>Origin and evolution of pathogenic coronaviruses.</article-title>
                    <source>

                        <italic toggle="yes">Nat. Rev. Microbiol.</italic>
</source>
                    <year>2019</year>;<volume>17</volume>(<issue>3</issue>):<fpage>181</fpage>&#x2013;<lpage>192</lpage>.
                    <pub-id pub-id-type="pmid">30531947</pub-id>
                    <pub-id pub-id-type="doi">10.1038/s41579-018-0118-9</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref45">
                <label>50</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Smith</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Anderson</surname>
                            <given-names>ER</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Cansado-Utrilla</surname>
                            <given-names>C</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>SARS-CoV-2 neutralizing antibodies in dogs and cats in the United Kingdom.</article-title>
                    <source>

                        <italic toggle="yes">Current Research in Virological Science.</italic>
</source>
                    <year>2021</year>;<volume>2</volume>:<fpage>100011</fpage>.
                    <pub-id pub-id-type="pmid">34377997</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.crviro.2021.100011</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref46">
                <label>51</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Sharun</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Tiwari</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Rahman</surname>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>SARS-CoV-2 vaccine for domestic and captive animals: An effort to counter COVID-19 pandemic at the human-animal interface.</article-title>
                    <source>

                        <italic toggle="yes">Vaccine.</italic>
</source>
                    <year>2021</year>;<volume>39</volume>(<issue>41</issue>):<fpage>7119</fpage>&#x2013;<lpage>7122</lpage>.
                    <pub-id pub-id-type="pmid">34782159</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.vaccine.2021.10.053</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref47">
                <label>52</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Hedman</surname>
                            <given-names>H</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Krawczyk</surname>
                            <given-names>E</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Helmy</surname>
                            <given-names>Y</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Host diversity and potential transmission pathways of SARS-CoV-2 at the human-animal interface.</article-title>
                    <source>

                        <italic toggle="yes">Pathogens.</italic>
</source>
                    <year>2021</year>;<volume>10</volume>(<issue>2</issue>):<fpage>180</fpage>.
                    <pub-id pub-id-type="pmid">33567598</pub-id>
                    <pub-id pub-id-type="doi">10.3390/pathogens10020180</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref54">
                <label>53</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Perera</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Ko</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Tsang</surname>
                            <given-names>O</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Evaluation of a SARS-CoV-2 surrogate virus neutralization test for detection of antibody in human, canine, cat, and hamster sera.</article-title>
                    <source>

                        <italic toggle="yes">J. Clin. Microbiol.</italic>
</source>
                    <year>2021</year>;<volume>59</volume>(<issue>2</issue>):<fpage>e02504</fpage>&#x2013;<lpage>e02520</lpage>.
                    <pub-id pub-id-type="pmid">33139421</pub-id>
                    <pub-id pub-id-type="doi">10.1128/JCM.02504-20</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref55">
                <label>54</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Hughes</surname>
                            <given-names>EC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Amat</surname>
                            <given-names>JAR</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Haney</surname>
                            <given-names>J</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>SARS-CoV-2 serosurveillance in a patient population reveals differences in virus exposure and antibody-mediated immunity according to host demography and healthcare setting.</article-title>
                    <source>

                        <italic toggle="yes">J. Infect. Dis.</italic>
</source>
                    <year>2021</year>;<volume>223</volume>(<issue>6</issue>):<fpage>971</fpage>&#x2013;<lpage>980</lpage>.
                    <pub-id pub-id-type="pmid">33367847</pub-id>
                    <pub-id pub-id-type="doi">10.1093/infdis/jiaa788</pub-id>
                    <pub-id pub-id-type="pmcid">PMC7798933</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref56">
                <label>55</label>
                <mixed-citation publication-type="other">
                    <collab>Centers for Disease Control and Prevention</collab>:
                    <article-title>Coronavirus disease 2019 (COVID-19) 2020 interim case definition, approved April 5, 2020.</article-title>
                    <year>2023</year>[cited 2023 February 9].
                    <ext-link ext-link-type="uri" xlink:href="https://ndc.services.cdc.gov/case-definitions/coronavirus-disease-2019-2020/">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref48">
                <label>56</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Stevanovic</surname>
                            <given-names>V</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Vilibic</surname>
                            <given-names>T</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Cavlek</surname>
                            <given-names>I</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Seroprevalence of SARS-CoV-2 infection among pet animals in Croatia and potential public health impact.</article-title>
                    <source>

                        <italic toggle="yes">Transbound. Emerg. Dis.</italic>
</source>
                    <year>2020</year>;<volume>68</volume>(<issue>4</issue>):<fpage>1767</fpage>&#x2013;<lpage>1773</lpage>.
                    <pub-id pub-id-type="pmid">33191649</pub-id>
                    <pub-id pub-id-type="doi">10.1111/tbed.13924</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref49">
                <label>57</label>
                <mixed-citation publication-type="other">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Garc&#x00ed;a</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Clara</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Jaramillo</surname>
                            <given-names>D</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Seroprevalence of exposure to SARS-CoV-2 in domestic dogs and cats and its relationship with COVID-19 cases in the city of Villavicencio, Colombia. figshare. [Dataset].</article-title>
                    <year>2022</year>.
                    <pub-id pub-id-type="doi">10.6084/m9.figshare.21271137.v2</pub-id>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
    <sub-article article-type="reviewer-report" id="report218010">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.152500.r218010</article-id>
            <title-group>
                <article-title>Reviewer response for version 3</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Boh&#x00f3;rquez</surname>
                        <given-names>Laura C.</given-names>
                    </name>
                    <xref ref-type="aff" rid="r218010a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-6698-395X</uri>
                </contrib>
                <aff id="r218010a1">
                    <label>1</label>FIND, Geneva, Geneva, Switzerland</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>13</day>
                <month>11</month>
                <year>2023</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2023 Boh&#x00f3;rquez LC</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport218010" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.125780.3"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>The authors have presented a prevalence study assessing the exposure to SARS-CoV-2 in domestic animals and its association to the COVID19 cases of their human owners, across 8 territorial entities in the city of Villavicencio, Colombia.</p>
            <p> </p>
            <p> The work is clearly presented and the authors cite relevant current literature.</p>
            <p> </p>
            <p> The study design is appropriate and technically sound; however, I suggest to clarify specifically what is the sample size estimated, and specify if it was estimated per commune. In the Sample size section in Methods the population assessed is referring to the anti-rabies vaccination campaign (68,651) and the formula used and parameters but it does not state the estimated &#x201c;n&#x201d; for this study.</p>
            <p> </p>
            <p> In the Statistical analysis section, please specify how the confidence intervals were calculated.</p>
            <p> </p>
            <p> I suggest to the authors to complement in the Methods section the minimization of bias, if it was considered before the study commence. For example, blinding test operators to the positivity status of the owners, selection of the test.</p>
            <p> </p>
            <p> Regarding the discussion please do not repeat all the results text again, and do not refer to the Table X or Figure Y, it is not necessary to duplicate it, that information is already detained in the Results section.</p>
            <p> </p>
            <p> The authors highlighted several times relationships or associations in comparisons that showed to be &#x201c;not statistically significantly different&#x201d;. It is not clear why, it seems they focus on the point estimates and do not consider the confidence intervals. I suggest these statements are based on the statistical measures, in that case, stating that there was not a statistical significant association or please state clearly how do you support your conclusions against the statistical evidence.</p>
            <p> </p>
            <p> Keeping in mind what the authors have highlighted, that this study is not assessing the transmission direction between pets and owners, the authors should be careful in the Discussion, Conclusion and Abstract sections, avoiding the statements such as that the evidence from this study show the dynamics of virus transmission. As it is not the case, I suggest to the authors to rephrase such sentences to, for example, the evidence show the association between sero-positivity in pets and COVID-19 human cases in owners.</p>
            <p> </p>
            <p> I suggest to the authors to complement in the Discussion section the specific limitations of the study (and potential risks of bias), this will enrich their discussion. For example, the selection of the tests, and its performance, because it seems that the performance declared by the manufacturer of the selected test is much higher for cats than for dogs and this could impact the results of this study.</p>
            <p> </p>
            <p> Typos: 
                <list list-type="bullet">
                    <list-item>
                        <p>&#x201c;if whether&#x201d; in Methods</p>
                    </list-item>
                    <list-item>
                        <p>&#x201c;Dis&#x201d; in Table 3</p>
                    </list-item>
                    <list-item>
                        <p>&#x201c;Ig&#x201d; but it refers to IgG in Figure 2</p>
                    </list-item>
                    <list-item>
                        <p>Spanish words in Table 4 (caninos, felinos, mascotas)</p>
                    </list-item>
                </list>
            </p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>Yes</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>Yes</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>Yes</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>Yes</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>Partly</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>Yes</p>
            <p>Reviewer Expertise:</p>
            <p>Diagnostics, Immunodiagnostics, Molecular Diagnostics, Research and Development of Diagnostics, Clinical Research of Diagnostics and Medical devices.</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
        </body>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report195444">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.152500.r195444</article-id>
            <title-group>
                <article-title>Reviewer response for version 3</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Forero</surname>
                        <given-names>Diego A.</given-names>
                    </name>
                    <xref ref-type="aff" rid="r195444a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-9175-3363</uri>
                </contrib>
                <aff id="r195444a1">
                    <label>1</label>School of Health and Sport Sciences, Fundaci&#x00f3;n Universitaria del &#x00c1;rea Andina, Bogot&#x00e1;, Colombia</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>15</day>
                <month>8</month>
                <year>2023</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2023 Forero DA</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport195444" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.125780.3"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>The authors have incorporated my previous suggestions into the revised manuscript. I have a minor comment: content of table 4 in the current version of the manuscript is in Spanish.</p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>Yes</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>Partly</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>Yes</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>Yes</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>Partly</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>Partly</p>
            <p>Reviewer Expertise:</p>
            <p>Human health; molecular biology</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
        </body>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report167139">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.145608.r167139</article-id>
            <title-group>
                <article-title>Reviewer response for version 2</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Forero</surname>
                        <given-names>Diego A.</given-names>
                    </name>
                    <xref ref-type="aff" rid="r167139a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-9175-3363</uri>
                </contrib>
                <aff id="r167139a1">
                    <label>1</label>School of Health and Sport Sciences, Fundaci&#x00f3;n Universitaria del &#x00c1;rea Andina, Bogot&#x00e1;, Colombia</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>4</day>
                <month>4</month>
                <year>2023</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2023 Forero DA</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport167139" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.125780.2"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>The authors took into account several of my previous comments (and it is evident in the revised manuscript). However, several minor aspects highlighted for me in my previous review remain to be considered in the revised manuscript: 
                <list list-type="bullet">
                    <list-item>
                        <p>A better description of the rationale of the main aim of the study is needed.</p>
                    </list-item>
                    <list-item>
                        <p>It is not clear, in the manuscript, whether the authors examined directly some of the animals, for key clinical signs.</p>
                    </list-item>
                    <list-item>
                        <p>The statistical analysis (statistical tests used to generate a p value) in table 2 is not clear.</p>
                    </list-item>
                    <list-item>
                        <p>Data for dogs in Figure 3 is still not clear.</p>
                    </list-item>
                    <list-item>
                        <p>Data for correlation analyses should be presented in the manuscript (or in a supplementary file).</p>
                    </list-item>
                    <list-item>
                        <p>In the Discussion section, authors must really keep into account the lack of statistical significance of some findings.</p>
                    </list-item>
                </list>
            </p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>Yes</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>Partly</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>Yes</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>Yes</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>Partly</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>Partly</p>
            <p>Reviewer Expertise:</p>
            <p>Human health; molecular biology</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
        <sub-article article-type="response" id="comment9850-167139">
            <front-stub>
                <contrib-group>
                    <contrib contrib-type="author">
                        <name>
                            <surname>Jaramillo Hern&#x00e1;ndez</surname>
                            <given-names>Dumar Alexander</given-names>
                        </name>
                        <aff>Universidad de los Llanos, Colombia</aff>
                    </contrib>
                </contrib-group>
                <author-notes>
                    <fn fn-type="conflict">
                        <p>
                            <bold>Competing interests: </bold>Don't have</p>
                    </fn>
                </author-notes>
                <pub-date pub-type="epub">
                    <day>2</day>
                    <month>7</month>
                    <year>2023</year>
                </pub-date>
            </front-stub>
            <body>
                <p>
                    <bold>1. A better description of the rationale of the main aim of the study is needed.</bold>
                </p>
                <p> </p>
                <p> Change accepted:</p>
                <p> </p>
                <p> R/ In the last paragraph introduction:</p>
                <p> </p>
                <p> Colombia, in December 2021, a lion exhibited symptoms of infection days after being in contact with a COVID-19 positive keeper. 28 However, seroepidemiological studies of exposure to SARS-CoV-2 by pet animals have not been reported to date in the country. 
                    <italic>Since the dissemination of SARS-CoV-2 in dogs and cats is weak and short-lived, anti-SARS-COV-2 antibody detection studies are the best choice to determine the circulation of this virus in these companion animals. Of course, the indirect ELISA screening tests that detect immunoglobulin anti-RBD S1 SARS-CoV-2 are called for their greater accuracy in diagnosis</italic>.</p>
                <p> </p>
                <p> Reiners, N, Schnurra, C, Trawinski, H, Kannenberg, J, Hermsdorf, T, Aebischer, A, et al. Performance of a SARS CoV-2 antibody ELISA based on simultaneous measurement of antibodies against the viral nucleoprotein and receptor-binding domain. Eur J Clin Microbiol Infect Dis. (2021) 40:2645&#x2013;9. doi: 10.1007/S10096-021-04284-5/TABLES/3</p>
                <p> </p>
                <p> 
                    <bold>2. is not clear, in the manuscript, whether the authors examined directly some of the animals, for key clinical signs.</bold>
                </p>
                <p> </p>
                <p> Change accepted:</p>
                <p> </p>
                <p> R/ In the last paragraph subtitle &#x201c;Sampling and inclusion criteria&#x201d;</p>
                <p> </p>
                <p> This survey also inquired whether the individuals that cohabited with the pet animals (spontaneous communication) had histories of positive or negative RT-qPCR testing for COVID-19, and 
                    <bold>
                        <italic>one of the survey questions was focused on the possibility for the owner to recognize if</italic>
                    </bold> whether there were histories of clinical signs of the animals, such as signs in the upper or lower respiratory tract, or non-specific digestive signs (e.g., vomiting, diarrhoea, among others)</p>
                <p> </p>
                <p> 
                    <bold>3. The statistical analysis (statistical tests used to generate a p value) in table 2 is not clear.</bold>
                </p>
                <p> </p>
                <p> R/ To determine the individual significance of each of the predictors introduced in a logistic regression model, the Z statistic and the Wald chi-test are used. Databases are included as a supplement that can be used to corroborate the data. At the epidemiological level, the confidence interval offers more information than the p value.</p>
                <p> </p>
                <p> 
                    <bold>4. Data for dogs in Figure 3 is still not clear.</bold>
                </p>
                <p> </p>
                <p> Change accepted:</p>
                <p> </p>
                <p> R/ Figure 3 will be change.</p>
                <p> </p>
                <p> 
                    <bold>5. Data for correlation analyses should be presented in the manuscript (or in a supplementary file).</bold>
                </p>
                <p> </p>
                <p> Change accepted:</p>
                <p> </p>
                <p> R/ The data are included as Table 4 in the article.</p>
                <p> </p>
                <p> 
                    <bold>6. In the Discussion section, authors must really keep into account the lack of statistical significance of some findings.</bold>
                </p>
                <p> </p>
                <p> R/ Change accepted:</p>
                <p> </p>
                <p> &#x201c;In the present study, the association between positive COVID-19 cases (RT-qPCR testing) in humans versus seropositivity in canines and felines from the eight communes of Villavicencio was weakly positive (Spearman's correlation of 
                    <italic>p = </italic>0.32). This significance may be influenced by the characterization of the survey, where due to social fear or ignorance some owners could indicate that they were not or had not been positive for the disease, while a strong positive relationship was expected, as in the case of the study conducted by Patterson et al. 
                    <underline>
                        <sup>29</sup>
                    </underline> in Italy. On the other hand, the study by Van Aart et al. 
                    <underline>
                        <sup>43</sup>
                    </underline> showed that none of the felines had been infected with SARS-CoV- despite the fact that these were living with their positive COVID-19 owners. &#x00a0;Therefore, these associations between species should be analysed considering different factors.&#x201d;</p>
                <p> </p>
                <p> Only this change is made, since throughout the discussion all the results obtained are taken into account, including the data that are not statistically significant.</p>
            </body>
        </sub-article>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report159713">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.138120.r159713</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Forero</surname>
                        <given-names>Diego A.</given-names>
                    </name>
                    <xref ref-type="aff" rid="r159713a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-9175-3363</uri>
                </contrib>
                <aff id="r159713a1">
                    <label>1</label>School of Health and Sport Sciences, Fundaci&#x00f3;n Universitaria del &#x00c1;rea Andina, Bogot&#x00e1;, Colombia</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>26</day>
                <month>1</month>
                <year>2023</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2023 Forero DA</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport159713" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.125780.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>The manuscript describes an analysis of seroprevalence of anti-SARS-CoV-2 IgG in a sample of 300 dogs and 135 cats from a city in Colombia. Several major and minor issues should&#x00a0;be addressed: 
                <list list-type="bullet">
                    <list-item>
                        <p>A better description of the rationale of the main aim of the study is needed - why are you studying only seroprevalence?</p>
                    </list-item>
                    <list-item>
                        <p>"SARS-CoV-2 seroprevalence of 9.1% (3.3% in canines and 5.8% in felines)" is not clear (it is not clear that&#x00a0;it is additive).</p>
                    </list-item>
                    <list-item>
                        <p>In "Villavicencio (Meta State)". "state" is not clear, in the context of the organization of Colombia.</p>
                    </list-item>
                    <list-item>
                        <p>A better description of the recruitment strategy for the current study would be useful.</p>
                    </list-item>
                    <list-item>
                        <p>In Methods, a better description of "commune" is needed.</p>
                    </list-item>
                    <list-item>
                        <p>It is not clear whether the authors examined directly some of the animals, for key clinical signs.</p>
                    </list-item>
                    <list-item>
                        <p>Key parameters, such as specificity and sensitivity, are not described for the ELISA assay used. In addition, in Methods it would be important to include citations to key previous papers using the same kit.</p>
                    </list-item>
                    <list-item>
                        <p>In Statistical analysis, a description of the specific R packages used is needed.</p>
                    </list-item>
                    <list-item>
                        <p>Table 2 is incomplete (the header for a group of rows is missing) and the statistical analysis in table 2 is not clear.</p>
                    </list-item>
                    <list-item>
                        <p>Figure 2 might be presented as supplementary information.</p>
                    </list-item>
                    <list-item>
                        <p>Figure 3 is not clear - it is not clear what is the signal for humans and what is the signal for animals; in addition authors might use colors in this figure.</p>
                    </list-item>
                    <list-item>
                        <p>Data for correlation analyses should be presented.</p>
                    </list-item>
                    <list-item>
                        <p>In the Discussion section, authors must keep into account the lack of statistical significance of some findings.</p>
                    </list-item>
                    <list-item>
                        <p>Possible cross-reactivity of the ELISA assay is not discussed in the manuscript.</p>
                    </list-item>
                    <list-item>
                        <p>Limitations of the current study and recommendations for future studies are needed.</p>
                    </list-item>
                </list>
            </p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>Yes</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>Partly</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>Yes</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>Yes</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>Partly</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>Partly</p>
            <p>Reviewer Expertise:</p>
            <p>Human health; molecular biology</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
        <sub-article article-type="response" id="comment9329-159713">
            <front-stub>
                <contrib-group>
                    <contrib contrib-type="author">
                        <name>
                            <surname>Jaramillo Hern&#x00e1;ndez</surname>
                            <given-names>Dumar Alexander</given-names>
                        </name>
                        <aff>Universidad de los Llanos, Colombia</aff>
                    </contrib>
                </contrib-group>
                <author-notes>
                    <fn fn-type="conflict">
                        <p>
                            <bold>Competing interests: </bold>The authors declare no conflict of interest.</p>
                    </fn>
                </author-notes>
                <pub-date pub-type="epub">
                    <day>10</day>
                    <month>2</month>
                    <year>2023</year>
                </pub-date>
            </front-stub>
            <body>
                <p>1. A better description of the rationale of the main aim of the study is needed - why are you studying only seroprevalence?</p>
                <p> </p>
                <p> R/ One of the main limitations of our study is the lack of economic support. We could have done more advanced studies such as seroincidence, detection of neutralizing antibodies, or isolation of viral genomic material. Nevertheless, we just study seroprevalence in order to include an important and representative sample size of cats and dogs in Villavicencio.</p>
                <p> </p>
                <p> 2. "SARS-CoV-2 seroprevalence of 9.1% (3.3% in canines and 5.8% in felines)" is not clear (it is not clear that&#x00a0;it is additive).</p>
                <p> </p>
                <p> R/ Change accepted:</p>
                <p> 
                    <bold>Methods</bold>
                </p>
                <p> 
                    <bold>Type of study and sample size</bold> paragraph</p>
                <p> Line 2 &#x201c;The sample was estimated using the formula for size by proportions in finite populations, using the results obtained by Patterson 
                    <italic>et al</italic>.
                    <sup>29</sup> as a reference of p, with SARS-CoV-2 seroprevalences of 3.3% in dogs and 5.8% in cats from Italy&#x201d;.</p>
                <p> </p>
                <p> 3. In "Villavicencio (Meta State)". "state" is not clear, in the context of the organization of Colombia.</p>
                <p> </p>
                <p> R/ Colombia is divided into 32 departments and one capital district (Bogot&#x00e1;). Each Department has a capital city. In the case of the Meta Department, the capital city is Villavicencio.</p>
                <p> Change accepted: The word &#x201c;State&#x201d; will be changed for Department on each occasion.</p>
                <p> </p>
                <p> E.g. 
                    <bold>Methods</bold>
                </p>
                <p> 
                    <bold>Sampling and inclusion criteria</bold> paragraph</p>
                <p> Line 1 &#x201c;The participants were selected based on their mandatory participation in the 2021 rabies vaccination campaign, carried out in Villavicencio (capital of Meta department) by the health secretary&#x201d;.</p>
                <p> However, in some publications the word &#x201c;state&#x201d; means &#x201c;departamento&#x201d;.</p>
                <p> </p>
                <p> 4. A better description of the recruitment strategy for the current study would be useful.</p>
                <p> </p>
                <p> R/ The inclusion and exclusion criteria used in order to estimate the sample size are mentioned under the subheading &#x201c;Sampling and inclusion criteria&#x201d;.</p>
                <p> </p>
                <p> Change accepted:</p>
                <p> The subheading will change to &#x201c;Sampling, inclusion, and exclusion criteria&#x201d;</p>
                <p> The sentence &#x201c;The animals that had consumed immunomodulatory medication (e.g., corticosteroid-type immunosuppressants) one week before the sampling were not included in the study.&#x201d; Will be changed for:</p>
                <p> &#x201c;We determined as exclusion criterion, the animals that had consumed immunomodulatory medication (e.g., corticosteroid-type immunosuppressants) one week before the sampling.&#x201d;</p>
                <p> </p>
                <p> 5. In Methods, a better description of "commune" is needed.</p>
                <p> </p>
                <p> R/ In Colombia, Departments are subdivided into municipalities which are in turn subdivided into &#x201c;corregimientos&#x201d; in rural areas and into &#x201c;comunas&#x201d; (communes) in urban areas. Each commune, in turn is divided into neighborhoods.</p>
                <p> </p>
                <p> Change accepted:</p>
                <p> 
                    <bold>Methods</bold>
                </p>
                <p> 
                    <bold>Sampling and inclusion criteria</bold> paragraph</p>
                <p> Line 2 &#x201c;A probabilistic sampling was conducted by randomly selected two-stage clusters of domestic dogs and cats from the eight communes (subdivisions) that compose the urban area of Villavicencio (Figure 1), &#x2026;&#x201d;.</p>
                <p> </p>
                <p> 6. It is not clear whether the authors examined directly some of the animals, for key clinical signs.</p>
                <p> </p>
                <p> R/ No, animals were randomly selected among those who participated in the rabies vaccination campaign. Once these were selected, a survey was applied, and one of the questions was related to the clinical signs.</p>
                <p> </p>
                <p> 7. Key parameters, such as specificity and sensitivity, are not described for the ELISA assay used. In addition, in Methods it would be important to include citations to key previous papers using the same kit.</p>
                <p> </p>
                <p> R/ Change accepted:</p>
                <p> 
                    <bold>Methods</bold>
                </p>
                <p> 
                    <bold>Immunoassay </bold>paragraph</p>
                <p> Line 1. IgG antibodies against the nucleocapsid protein (N) of SARS-CoV-2 in the sera of domestic dogs and cats were qualitatively determined using the indirect enzyme-linked immunosorbent assay (ELISA) (ID Screen
                    <sup>&#x00ae;</sup> SARS-CoV-2, double antigen multi-species [IDvet, Grabels, France]) according to the manufacturer's instructions. For cats, the kit presents 63% of sensitivity and 96% of specificity. For dogs, the kit has 36% of sensitivity and 85% of specificity. Previous papers used the ID Screen
                    <sup>&#x00ae; </sup>kit in their studies (48-51).</p>
                <p> </p>
                <p> 
                    <bold>References</bold>
                </p>
                <p> 48. Bessi&#x00e8;re P, Vergne T, Battini M, Brun J, Averso J, 
                    <italic>et al</italic>.: 
                    <bold>SARS-CoV-2 Infection in Companion Animals: Prospective Serological Survey and Risk Factor Analysis in France</bold>. 
                    <italic>Viruses</italic>. 2022; 
                    <bold>14</bold>(1178). 
                    <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/35746652/">PubMed Abstract</ext-link> I 
                    <ext-link ext-link-type="uri" xlink:href="https://www.mdpi.com/1999-4915/14/6/1178">Publisher Full Text</ext-link>
                </p>
                <p> </p>
                <p> 49. Diezma-D&#x00ed;az C, &#x00c1;lvarez-Garc&#x00ed;a G, Regidor-Cerrillo J, Mir&#x00f3; G, Villanueva-Saz S, 
                    <italic>et al</italic>.: 
                    <bold>A comparative study of eight serological methods shows that spike protein-based ELISAs are the most accurate tests for serodiagnosing SARS-CoV-2 infections in cats and dogs</bold>. 
                    <italic>Front. Vet.</italic> 2023. Sci. 
                    <bold>10</bold>(1121935). 
                    <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fvets.2023.1121935/full">Publisher Full Text</ext-link>
                </p>
                <p> </p>
                <p> 50. Barua S, Hoque M, Adekanmbi F, Kelly P, Jenkins-Moore M, 
                    <italic>et al</italic>.: 
                    <bold>Antibodies to SARS-CoV-2 in dogs and cats, USA</bold>. 
                    <italic>Emerg Microbes Infect.</italic> 2021. 
                    <bold>10</bold>(1):1669-1674. 
                    <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/34374631/">PubMed Abstract</ext-link> I 
                    <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/22221751.2021.1967101">Publisher Full Text</ext-link>
                </p>
                <p> </p>
                <p> 51. Neira V, Brito B, Ag&#x00fc;ero B, Berrios F, Vald&#x00e9;s V, 
                    <italic>et al</italic>.: 
                    <bold>A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners</bold>. 
                    <italic>Emerg Microbes Infect</italic>. 2021. 
                    <bold>10</bold>(1):376-383. 
                    <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33317424/">PubMed Abstract</ext-link> I 
                    <ext-link ext-link-type="uri" xlink:href="https://www.tandfonline.com/doi/full/10.1080/22221751.2020.1863132">Publisher Full Text</ext-link>
                </p>
                <p> </p>
                <p> 8. In Statistical analysis, a description of the specific R packages used is needed.</p>
                <p> </p>
                <p> R/ Change accepted:</p>
                <p> 
                    <bold>Methods</bold>
                </p>
                <p> 
                    <bold>Statistical analysis </bold>paragraph</p>
                <p> Line 9. Statistical estimates were made using the R 4.2 software with the packages dplyr, MASS, corrplot and epiDispaly, and the maps using the QGIS 3.10 software.</p>
                <p> </p>
                <p> 9. Table 2 is incomplete (the header for a group of rows is missing) and the statistical analysis in table 2 is not clear.</p>
                <p> </p>
                <p> R/ In theTable 2, the header of the row 1, 2, 3, 4 &#x2026; 8: is &#x201c;Communes&#x201d;. This header is included in the original manuscript.</p>
                <p> </p>
                <p> On the other hand, statistical analysis included in table 2 are described in the fourth paragraph of results:</p>
                <p> </p>
                <p> Line 1 &#x201c;Regarding the SARS-CoV-2 exposure and the risk factors analysed, a statistically significant association between SARS-CoV-2 seropositivity and Commune 2 was found (adjusted OR = 5.84; CI 95% = 1.1-30.88).&#x201d;</p>
                <p> </p>
                <p> 10. Figure 2 might be presented as supplementary information.</p>
                <p> </p>
                <p> R/ Change not accepted, it is important to show the OD distribution among communes, showing the positive results and grey area results.</p>
                <p> </p>
                <p> 11. Figure 3 is not clear - it is not clear what is the signal for humans and what is the signal for animals; in addition authors might use colors in this figure.</p>
                <p> </p>
                <p> R/ Change accepted:</p>
                <p> 
                    <bold>Results</bold>
                </p>
                <p> Figure 3 will be change by the colored one.&#x00a0;</p>
                <p> </p>
                <p> 12. Data for correlation analyses should be presented.</p>
                <p> R/ Change not accepted, here we present a table with the data for the correlation analyses about the association between positive COVID-19 cases (RT-qPCR testing) in humans versus seropositivity in pets. Nevertheless, it is not necessary to show the table in the paper, since we mention the important data in the discussion (paragraph 4, line 10).</p>
                <p> </p>
                <p> &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; Human&#x00a0; &#x00a0;Dogs&#x00a0; &#x00a0; Cats&#x00a0; &#x00a0; Pets</p>
                <p> Dogs&#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; 0,01&#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0;1&#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0;--&#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; --</p>
                <p> Cats&#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; 0,33&#x00a0; &#x00a0; &#x00a0; &#x00a0;0,17&#x00a0; &#x00a0; &#x00a0; 1</p>
                <p> Pets&#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0; &#x00a0;0,32&#x00a0; &#x00a0; &#x00a0; 0,68&#x00a0; &#x00a0; 0,81*&#x00a0; &#x00a0; &#x00a0; &#x00a0;1</p>
                <p> *
                    <italic>p</italic>-value = 0.01467</p>
                <p> </p>
                <p> 13. In the Discussion section, authors must keep into account the lack of statistical significance of some findings.</p>
                <p> </p>
                <p> R/ In the results and discussion sections, we mentioned and pointed out that results were not significant (just the results associated with commune 2 were statistically significant); however, there were trends that correlate with other studies and we mentioned them explaining that these were not significant (Eg. Discussion paragraph 2, line 1):</p>
                <p> &#x201c;As a result of the present study, a positive relationship between seropositivity and the age of the animals was observed. The older animals between 11 and 15 years exhibited this tendency predisposition, 
                    <underline>but it was not statistically different</underline>&#x201d;.</p>
                <p> 14. Possible cross-reactivity of the ELISA assay is not discussed in the manuscript.</p>
                <p> </p>
                <p> R/&#x00a0;Change accepted: The following paragraph will be added to the discussion section.</p>
                <p> 
                    <bold>Discussion </bold>
                </p>
                <p> Although the 20 canine pre-pandemic sera reacted negatively to the immunodiagnosis, cross-reactions with ancestral coronaviruses in canines and felines are possible, but in low probability when are compared to commercial ELISAs with neutralizing antibody tests (54, 55).</p>
                <p> </p>
                <p> 54. Perera R, Ko R, Tsang O, Hui D, Kwan M 
                    <italic>et al</italic>.: 
                    <bold>Evaluation of a SARS-CoV-2 surrogate virus neutralization test for detection of antibody in human, canine, cat, and hamster sera.</bold> 
                    <italic>J Clin Microbiol</italic>. 2021;59(2):e02504&#x2013;20.
                    <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33139421/"> PubMed Abstract</ext-link> I 
                    <ext-link ext-link-type="uri" xlink:href="https://journals.asm.org/doi/10.1128/JCM.02504-20">Publisher Full Text</ext-link>
                </p>
                <p> </p>
                <p> 55. Hughes EC, Amat JAR, Haney J, Parr J, Logan N, 
                    <italic>et al</italic>.: 
                    <bold>SARS-CoV-2 serosurveillance in a patient population reveals differences in virus exposure and antibody-mediated immunity according to host demography and healthcare setting</bold>. 
                    <italic>J Infect Dis</italic>. 2021;223(6):971-980. 
                    <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/33367847/">&#x00a0;PubMed Abstract</ext-link> I 
                    <ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/jid/article/223/6/971/6052401">Publisher Full Text</ext-link>
                </p>
                <p> </p>
                <p> 15. Limitations of the current study and recommendations for future studies are needed.</p>
                <p> </p>
                <p> R/ Change accepted: The following paragraph will be added to the discussion section.</p>
                <p> 
                    <bold>Discussion </bold>
                </p>
                <p> The possible cross-reactivity and the need to verify if the reactive antibodies are neutralizing for SARS-CoV-2 are the main limitations of our study; likewise, it is advisable to carry out studies of SARS-CoV-2 neutralization from the serum bank obtained, since this is the gold-standard test for the Centers for Disease Control and Prevention (CDC) (56).</p>
                <p> </p>
                <p> 56. Centers for Disease Control and Prevention.
                    <bold> Coronavirus disease 2019 (COVID-19) 2020 interim case definition, approved April 5, 2020.</bold>
                    <bold> </bold>2023 [cited 2023 February 9]. &#x00a0;
                    <ext-link ext-link-type="uri" xlink:href="https://ndc.services.cdc.gov/case-definitions/coronavirus-disease-2019-2020/">Reference Source</ext-link>
                </p>
            </body>
        </sub-article>
    </sub-article>
</article>
